when stress results in
muscle strain and pain
When the normally sedentary person suddenly turns
active-cleaning the attic, for instance-the outcome
is sometimes a strain or sprain in the back, neck or
shoulders.
Fortunately, however, most patients with muscle
spasm and pain are highly responsive to therapy
with Robaxisal. This rationally based formula provides the well-known relaxant benefits of methocarbamol for strained, tense skeletal muscle plus the
dependable analgesic and anti-inflammatory effects
of aspirin. Investigators have found methocarbamol
a well-tolerated agent with "specificity of action.m
And methocarbamol potentiates the salicylate levels
of aspirin so that, in combination,.higher salicylate
levels are produced than with equivalent doses of
aspirin alone. 2 When the Robaxisal combination*
was administered to a group of 22 patients with
painful musculoskeletal disorders, 20 (91 per cent)
showed an excellent or good response.2
With Robaxisal you can conveniently fulfill the most
importJ.nt objectives in treatment of muscle spasm:
relaxation of skeletal muscle, relief of pain, restoration of mobility and normal muscle tone. And when
mild anxiety is a factor in the spasm-pain syndrome,
consider Robaxisal®-PH.
""I n th is investigation , 400 mg. methoca rbamol was combined with 300 m g. aspirin.
Refe rences: 1. W eiss, M., and Weiss, S.: ]. Am. O s teopath. A. 62:142, 1962. 2. T ruitt,
E.B., Jr.; Morgan , A.M., and Nachman , H.M.: South. M .j . 54 :318, 1961.

!!~baxisal®brings relief
Each pink and white laminated tablet contains :
Robaxin (methocarbamol, Robins) ... .. . .. . ... 400 mg.
U. S. Pat. No. 2770649
Aspirin (S gr.) .. . ... .. . . ... . . ... . .. ... ... . . 325 mg .

fior ti0 th

Robaxisal0 -PH
Each green a nd white laminated tablet con tains:
Robaxin (methocarbamol, Robins) . . . .... ... . . 400 mg.
Phenacetin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97 mg.
Aspirin .... ........ ... . . .. . .......... . .. . ... 81 mg.
Phenobarbital (1/ 8 gr.) ...... ............. . . . 8.1 mg.
(Warning: May be habit forming)
Hyoscyamine sulfate . . . . . . .....• •...• . .... 0.016 mg.

Robaxisal a nd Robaxisal-PH a re indica ted when both analgesic a nd
skeletal muscle relaxant effects are required, as in strains and· sprains,
painful disorders of the back, " whiplash" injury, myositis, pain and
spasm associa ted with arthritis, torticollis, and headache associated
with muscu lar tension.
Contraindications: H ypersensitivity to any one of the components.

DIOBINS A.RICHMOND,
H . ROBINS COMPANY~ INC.
A·H·_Ix
VIRGINIA 23220

Side Effects: Lightheadedness, slight drowsiness, d izzin ess, and nausea
may occur rarely in patients with unusual sensitivity to drugs, but
u sually disappear on reduction of dosage.
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Pancreatitis
FRANZ J. INGELFINGER*

The New England Journal of Medicine, Boston, Massachusetts 02115

I am, of course, most grateful to
everyone responsible for arranging
this-the 39th McGuire Lecture
Series. It is a series distinguished
by tradition: few medical lectureships can point to a continuity of
nearly 40 years, and few can
boast of the three M's of American
medicine-Mayo, Mann and Minot.
Incidentally, in going over the list
of previous lectures, I could not
help noticing that I am the eighth
Bostonian in this series, which puts
us well ahead of our nearest competitor, a clinic in a state with a
name that also happens to begin
with M.
My pleasure at being invited to
give this Stuart McGuire Lecture
has naturally been doubled-and I
am speaking in logarithmic termsby having on the same program 11
men who had, let us say, some experience in our gastrointestinal section in Boston. Dr. Farrar, Dr.
Caravati and others, in arranging
this, were doubtlessly motivated by
generosity but also probably felt a
bit sorry for the old man who has
entered what some regard as the
retirement of an editorship.
The subject of my lecture requires better definition: I shall talk
about pancreatitis and, chiefly,
about the diagnosis of the recurrent
variety of pancreatitis. How can we
recognize the pain of this disease?
This pain does tend to be in the
upper abdomen, more often on the
left than the right, and radiates to the back in about a quarter

* Thirty-Ninth Annual McGuire
Lecturer for the McGuire Lecture
Series, November 9-10, 1967, Medical
College of Virginia, Richmond.
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of the cases. It has, however, no
characteristic quality, and the degree of the pain may range from
the relatively painless to the excruciating. Most often, its severity
is between these two extremes.
In an essay on pain published in
1930, Dr. Stuart McGuire wrote
as follows:
In considering the significance of

pain which occurs in patients who
are suddenl y taken with belly-ache,
the vital question to decide is whether
it is caused by an acute intra-abdomina l disease such as appendicitis,
cholecystitis, perforating ulcer or intestinal obstruction-conditions which
demand prompt operative intervention-or whether it is reflex from
extra-abdominal diseases such as
tabes, angina, pneumonia, lead poisoning, rheumatic conditions or diseases of the upper urinary tractconditions which call for medical
rather than surgical treatment.
Note that, among the common
causes of abdominal pain listed,
pancreatitis does not appear. He
certainly knew about pancreatitis,
but my guess is that Dr. McGuire
considered it an uncommon ailment. The Index Medicus in those
years usually had less than 50 entries annually relating to pancreatitis, and chronic or recurring pancreatitis was hardly mentioned. In
contrast, the 1966 Index Medicus
contained over 350 entries, and as
one scans the list, the preponderance of reports originating either
from the United States or France
is striking. Articles from Israel, on
the other hand, are conspicuously
absent. Indeed, when an experienced
surgeon from Israel was recently
shown one of Boston's many patients with chronic alcoholic pan-

creatltls, he doubted the diagnosis.
Why? Because, he said, it was such
a very, very rare disease. He had
never seen a case.
Alcohol the Villain

What do the United States and
France have that Israel does not?
Enthusiastic consumption of alcohol. The evidence is very suggestive
that the prevalence of pancreatitis
and the consumption of alcohol
show parallel trends in various areas
of the world, even as cirrhosis and
alcohol consumption show parallel
trends. The beer-drinking Bantu of
South Africa, for example, not only
has much cirrhosis; he also has
much chronic pancreatitis.
Dr. Gerald Klatskin of Yale likes
to show a graph plotting deaths
from cirrhosis against years. After
the enactment of prohibition, the
rate fell sharply from about 12 to
7 per 100,000, but after drinking
became legal again, the death rate
from cirrhosis steadily rose to a
level of about 11(Klatskin,1961).
Adequate figures for plotting the
incidence of pancreatitis over the
years are not available, but my
guess is that this incidence has
steadily gone up since the repeal
of prohibition.
The relation of pancreatitis to
alcohol consumption is not only
of epidemiologic interest but also
has a bearing on our subject: abdominal pains in a patient who
drinks alcohol should make one
think of pancreatitis. You may regard this as too obvious. But the
following happens again and again
in Boston, and I suspect elsewhere
as well. A patient complains that
he has vomited and has abdominal
MVC QUARTERLY 4 (1): 4-9, 1968
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pain coming on a few hours after
some reasonably heavy drinking.
The vomitus may or may not contain blood, but the chances are
nearly 100% that a diagnosis of
alcoholic gastritis will be made. The
same story may repeat itself a few
times until someone happens to
take a serum amylase which, if elevated, helps establish the correct
diagnosis. Serum amylase, however,
is not always elevated under such
conditions, and the correct diagnosis may never be suspected until
an abdominal x-ray one day reveals calcification in the pancreas.
Not all abdominal pains in patients who have been drinking are
caused by pancreatitis, but the possibility is a real one. That alcoholic
gastritis is responsible for abdominal pains appearing in the drinking
patient, however, is not a good possibility for the simple reason that
the existence of such an entity is
controversial and, in any case, its
symptomatology quite obscure. No
one has yet shown that the histologic appearance of the stomach
in the patient who is drinking is
different from that found in a control population, or that the gastroscopic appearance of the stomach
in a patient vomiting because of
alcoholism looks different from
that of a patient vomiting for some
other reason.
It is,. of course, silly to talk about
drinking without defining its degree.
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TABLE 1
Associates of Pancreatitis
Causal(%)
50

25
7
4
?
1
0
2

1

10

Re

Alcohol
Gallstones
Peptic Ulcer
Trauma
Malnutrition
Parasites
Diabetes
Other Metabolic Diseases
Drugs
None of these
If "none": chances of pancreatitis

< 10%

considered the primary cause of
pancreatitis, responsible for some
80% of attacks. Their contribution
to the etiology of pancreatitis, however, is rapidly decreasing, partly
on a relative basis because of the
increasing frequency of alcoholic
pancreatitis, and partly because
symptomatic gallstones are so
promptly removed these days that
pancreat1tls caused by neglected
biliary tract disease is becoming a
rarity.
Whether peptic ulcer really initiates pancreatitis by eroding into
the pancreas, with subsequent
spread to involve more of the organ,
is controversial. In my opinion it
is an uncommon but not rare antecedent of pancreatitis.
Trauma clearly appears to be an
antecedent of pancreatitis, sometimes on the table . and sometimes
off. The "on the table" variety is
usually precipitated by vigorous
manipulation of the upper abdominal cavity during the course of gastroduodenal or biliary tract surgery.
The "off the table" kind is caused
by blunt and non-penetrating
trauma to the belly such as occurs
when the body is thrown against a
steering wheel, or when someone
dives into a swimming pool, not
realizing that the water has been
emptied out of it. Since this phenomenon admittedly is only apt to
happen under certain conditions,
the dilemma is posed whether the
dive or the pre-dive alcohol is responsible. As a matter of fact, with
the exception of gallstones, the
same question applies to most of
the possible background conditions
listed . Many a patient with pancreatitis, for example, has both
peptic ulcer and a tendency to
drink alcohol in excess.
Malnutrition is often invoked as
a background condition responsible
for pancreatitis, because the pancreas is histologically altered in
kwashiorkor and because the methionine antagonist, ethionine, produces a chronic pancreatic reaction
in experimental animals. Direct evidence, however, is lacking. Many
5

PANCREATITIS

natives of Uganda, to be sure, have
chronic pancreatitis with calcification of the organ, but Ugandans
appear to be as intemperate as
Americans and French, and, hence,
the problem is again one of selecting the real culprit from at least
two candidates.
Another disorder apt to affect
malnourished populations is parasitism. The parasite most apt to cause
pancreatitis is Ascaris lumbricoides,
which crawls into the common duct
to obstruct it. In our adult US
population, especially in people
of higher socio-economic status,
ductal pancreatic obstruction by this
mechanism is almost unheard of.
On the other hand, if a population
of children in an impoverished tropical country is under consideration,
parasitism turns out to be the principal cause of pancreatitis. These
facts underscore the difficulty of
arriving at universally applicable
percentage figures for the frequency
of various etiologies of pancreatitis.
The figures shown in Table 1 are
approximations of the crudest type.
Metabolic diseases other than
diabetes have been well publicized
as causes of pancreatitis, and the
recent literature incriminates a number of drugs that are also suspect
(Table 2) . Although fascinating
because of their diagnostic and etiologic implications, metabolic disorders and drug reactions account,

TABLE2
Conditions and Drugs Suspected
of Causing Pancreatitis
Metabolic Disorders:

Hyperlipemia
Hyperparathyroidism
Amino-aciduria (cysteine

+ lysine)

Drugs:

ACTH and Adreno- lsoniazid
cortical Agents
Sulfamethizole
Opiates
Thiazides
Carbon
tetrachloride
Indomethacin
Methyl
alcohol
6

at least in my opinion, for only a
small proportion of all cases of
pancreatitis. When hyperlipemia is
associated with pancreatitis, either
condition may be cart or horse. Patients with essential hyperlipemia
are, for unknown reasons, susceptible to attacks of pancreatitis. Conversely, hyperlipemia in other instances is the consequence of
repeated attacks of pancreatitis,
often alcoholically induced. Hyperlipemia, thus, may be found inconstantly in about 5 % of patients
with chronic recurrent pancreatitis,
and, when present, may in some
mysterious way suppress the increases in serum amylase and lipase
usually expected when pancreatic
inflammation is active ( Greenberger et al., 1966).
The association of pancreatitis
with hyperparathyroidism also tends
to be emphasized, but the absolute
number of such cases is small, except at the Massachusetts General
Hospital, a magnet for patients
with parathyroid dysfunction. At
this famous institution, indeed, the
significance of blood calcium levels
is uncertain, for obviously the hypercalcemia of hyperparathyroidism and the hypocalcemia of severe
pancreatitis may cancel each other.
Finally, pancreatitis appears to be
associated in certain families with
amino-aciduria, particularly of lysine and cysteine. In a number of
these patients, however, alcoholic
intake is heavy, and, again, the
real criminal is hard to identify.
The situation resembles that of
hemochromatosis. Many think that
hemochromatosis is a genetically
transmitted disorder, but since so
many hemochromatotics drink, one
almost has to assume that a penchant for drinking alcohol is also
genetically transmitted.
In about 10% of the cases, pancreatitis affects a patient who has
no recognizable background condition.
Complications of Pancreatitis

Many of the disorders listed in
Table 1 may be re~arded as the

consequences (right-hand column
of percentage figures) rather than
the causes of pancreatitis. Is it
really true that 1% of patients
are alcoholic because they have
pancreatitis? I doubt it, but, at one
time, when alcoholism was not a
socially acceptable diagnosis, it was
suggested that some people took
up drinking because their abdominal pain was so bad. It reminds me
of one of our patients who always
made the two-glass test when he got
one of his attacks of pancreatitis.
With the onset of pain, he would
promptly repair to the local bar
and take two shots of whiskey. If
this made the pain disappear, well
and good-he could drink more. If
it did not make the pain disappear,
he had to keep on drinking so that
he might forget the pain.
Can chronic pancreatitis cause
gallstones? There is considerable
evidence that one of the background conditions necessary for
precipitation of biliary sediment is
stasis, and, hence, chronic pancreatitis, to the extent that it obstructs
the biliary passages, may lead to
the production of gallstones. The
5 % is obviously a very rough guess.
The precipitation of pancreatitis
by peptic ulcer is, as I have indicated, debatable. On the other hand,
there is very good evidence to suggest that peptic ulcer may result
from chronic pancreatic insufficiency. The patient who puts out
pancreatic juice grossly deficient in
bicarbonate because of pancreatic
insufficiency obviously cannot neutralize gastric contents in a normal
fashion, and, hence, his duodenal
contents may be abnormally acid.
In addition, it has been shown that
the absence of normal pancreatic
juice in the duodenum itself stimulates gastric secretion. Thus, both
enhanced gastric acid secretion and
decreased neutralization of the duodenum join forces to make the patient with chronic pancreatic disease susceptible to peptic ulcer.
Try as I might, I could not figure
out how pancreatitis would lead to
increased trauma, unless one wanted
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to argue that the driver seized by
the belly pain of pancreatitis will
smash into somebody else. If pancreatitis is so severe that pain and
vomiting interfere with eating, or
if digestion is impaired by pancreatic insufficiency, malnutrition obviously ensues. Similarly, diabetes is
a frequent concomitant and result
of chronic pancreatitis. Many patients with chronic pancreatitis use
narcotics and, after a while, it is
hard to tell whether they are addicted or really need the medication. In any case, abuse of narcotic
drugs is certainly the result in some
patients with pancreatitis. To the
extent opiates and meperidine cause
further spastic ohstruction at the
sphincter of Oddi, the use of these
drugs may in turn aggravate the
original disease.
The percentage figures in both
columns of Table 1 are not only
imprecise; they are also grossly
affected by a great deal of overlap.
Many patients with pancreatitis
have both diabetes and malnutrition. If the percentages indicating
prevalence on both sides are added,
their total is 180%, as might be
expected, since one patient with
pancreatitis often has several associated conditions.
The diagnostic importance of
Table 1 is that there are relatively
few patients with pancreatitis who
have no associated conditions whatsoever. When the prevalence of conditions associated, for one reason
or another, with pancreatitis is taken
into account, one may logically
conclude that less than 10% of
patients with pancreatitis have pancreatitis all by itself, without any
of the conditions listed in Table 1.
Put another way, this means that,
if one sees a patient with upper abdominal pains of unexplained nature and he has none of these
conditions associated with pancreatitis, the chances are less than 10%
that he is suffering from pancreatitis. The converse is, of course, not
true. Many patients with abdominal
pain have alcoholism, gallstones, or
diabetes and are not necessarily suf-

fering from pancreatitis. The list in
Table 1 presents criteria that are
negatively important : their absence
militates against the diagnosis of
pancreatitis.
Extra -Pancreatic Manifestations
Recognition of pancreatic pain
is not only aided by an awareness
of those conditions that are associated historically with pancreatitis.
Equally helpful are extra-pancreatic phenomena often appearing
during the acute episode (Table 3).
The presence of such phenomena
is related to the severity of the
attack. The more drastic the attack,
the more likely that other systems
will be involved . Particularly frequent are radiologic signs of pleural
or pulmonary changes; even in
the moderate cases, one may expect
them about a third of the time. The
cardiovascular reactions to severe
pancreatitis are well-known. Less
emphasized are some of the unusual
manifestations of fat necrosis such
as aching in the bones, possibly
related to necrosis of marrow fat,
and, very rarely, subcutaneous nodules reminiscent of Weber-Christian
syndrome. One of the explanations
for the tetany that occurs a few
days after an attack of severe pancreatitis is liberation of free fatty
acids which then, in turn, bind calcium to form soaps.
Central nervous system disorders
associated with pancreatitis are
sometimes striking. In my experience they have been limited to
those patients who have alcoholic
pancreatitis and, consequently, are
particularly susceptible, because of
chronic cerebral damage, to the
vascular and blood flow derangements that attend pancreatitis. In a
few cases, in addition, large doses
of atropine or of similar agents
given for therapy aggravate the delirium.
Bleeding phenomena, although
unusual, do take place, and one of
the most striking is the appearance
of a bluish-black discoloration on
the flanks, the so-called Grey-Tur-

ner sign. How do you spell it? Is
it with an e or with an a? Whichever it is, is it hyphenated or not?
Is it one person or two persons?
Man or woman? I ask these questions because journals and textbooks
seem to be quite inconsistent. One
textbook spells it with an a; another one seems to hyphenate it
in some places and not in others. I
emphasize this type of niggling because it epitomizes the editor's life,
and only editorial experience reveals the intricacies of truth. It
was just one person. There was no
hyphen ever between the Grey and
the Turner. However, it is apparently correct usage that if a man's
two names are used as an adjective,
then the hyphen is properly placed
between them. Grey Turner, the
man, is not hyphenated, but GreyTurner sign is.
·
The Enzymatic Attack
What is responsible for all these
phenomena, as well as for the major presenting complaint- namely,
that of pain? Presumably it is the
digestive enzymes of the pancreas

TABLE 3
Pancreatitis: Involvement
of Other Systems
Pleura-Lungs : effusions, infiltrations
Cardiovascular : shock. hypovolemia
Fat Depots
: necrosis (deep, bone,
subcutaneous)
(tetany)
CNS
: delirium
Clotting
: hemorrhages

TABLE 4
Pancreatic Enzymes
Trypsin
Chymotrypsin
Carboxypeptidase
Phospholipase A
(Lecithinase,
Phosphatidase)
Elastase
Collagenase

Lipase
Other Esterases

Amylase
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attacking the patient's own tissues.
Proteolytic and lipolytic ferments,
listed in Table 4, are disrupting
the basic constituents of tissue. Interestingly enough, amylase, the
enzyme which we most depend
upon for diagnosis, presumably
does little damage when it accumulates in the bloodstream.
Since trypsin and its congeners
are so implicated in initiating and
perpetuating both the local and distant deleterious effects of pancreatitis, it would seem reasonable to
measure the activity of these proteolytic enzymes in the blood and
other body fluids , not only for the
purpose of diagnosis, but also to
assess the severity of the processmuch as we use transaminases in
the diagnosis of acute liver disease.
A priori tests of proteolytic activity should be easy to devise.
Trypsin was one of the first mammalian digestive enzymes to be isolated and crystallized, practically 40
years ago. The brilliant research of
Neurath and others, furthermore,
has defined in a nearly complete
fashion both the chemical and steric
structure of trypsin and chymotrypsin, and of their inactive precursors,
trypsinogen and chymotrypsinogen
(Neurath, 1964) . Chymotrypsinogen, the longer chain of the two,
consists of 246 amino acids in a
curlicue chain interlinked at various
points by sulfide bridges. When the
terminal 15 amino acids are split
off, the enzyme becomes active, i.e. ,
it is chymotrypsin, presumably because removal of the end chain
permits steric reorganization with
the creation of active enzymatic
sites. The chain of trypsinogen in
general looks about the same except that it contains 229 rather
than 246 amino acids.
Though trypsin and chymotrypsin look alike, they are highly fastidious in selecting where they attack the proteins they digest. Amino
acids making up proteins are joined
by bridges that form between amide
and carboxyl terminals of amino
acids. When trypsin splits the peptide linkages, it attacks only those
8

that are next to an amino acid with
a positively charged side group,
such as arginine. Chymotrypsin
splits only bridges that are next to
amino acids with a six-carbon ring,
such as tyrosine.
So what more is needed? The
perpetrators of pancreatitis, trypsin
and chymotrypsin, are chemically
recognized, and specific substrates
are available to catch them. Indeed ,
this substrate specificity has been
exploited by the synthesis of relatively simple materials and by the
use of these, rather than of complex
proteins, for substrates. For example, an amide of a derivative of
arginine can be made, such as
benzoyl argininamide. If this is exposed to trypsin, ammonia is split
off, and this ammonia can be measured to obtain an expression of
tryptic activity. This principle was
first used in the 1930's but was
revived about ten years ago as
a means of measuring tryptic activity in the blood. More recent
modifications have improved the
procedure technically. Trypsin and
chymotrypsin do not care about
the ends of the substrate molecule.
If an ester is formed by combining
an arginine derivative with methyl
or ethyl alcohol, tryptic activity can
be measured by titrating the acidity
liberated by digestion of the ester.
If a tyrosine derivative is used,
chymotrypsinogen can be similarly
measured .
Problems of Testing Proteolysis
The method does not appear to
yield reliable and consistent results
when proteolytic activity in the
blood is assayed. There are two
major reasons for this. In the first
place, though trypsin is fastidious,
other substances are similarly fastidious and attack the same amino
acid linkage. Thus, thrombin, plasmin or fibrinolysin, the first component of complement, and a serum
esterase split ammonia from a substrate such aJ; benzoyl argininamide.
Trypsin is specific in that it attacks
only a certain type of peptide link-

age, but the substrate is not specific
for trypsin.
The second difficulty is that the
body appears to react to proteolytic
activity as nature reacts to a vacuum. Whenever proteolytic activity starts to appear in excess, inhibitory substances appear with
equal rapidity in an effort to control
autodigestion. Some of the very
products of tryptic digestion may in
themselves be inhibitory. But even
in the absence of excess proteolytic
activity, body tissues and fluids are
well supplied with anti-tryptic substances. Indeed, pancreatic juice in
its native stage contains an inhibitor
of proteolytic activity, and it may
be that enhancement of tryptic digestion is at times attributable less
to increased trypsin than to decreased concentration of inhibitor.
The difficulty of recognizing pancreatitis in its moderate and early
stages has encouraged a number of
ingenious diagnostive approaches.
Water, bicarbonate and enzyme output by the pancreas, stimulated by
secretin and pancreozymin, can be
measured with reasonable satisfaction in the intact human subject.
Though direct x-ray of the pancreas is still a goal to be achieved,
the organ can be outlined by scanning after giving selenium-75-methionine. Subselective angiography
may at times detail the small
branches of the arterial system
supplying the pancreas. All these
methods are highly successful in
the advanced cases of pancreatitis,
but in such cases, simpler means
suffice to make the diagnosis. The
usefulness of angiographic and isotopic methods in diagnosing early
or diffuse pancreatitis is still circumscribed, and I doubt that they
will improve markedly in this respect within the next ten years.
The Amylase Test
Our diagnostic skill must thus
rest, as it has rested, on measuring
the pancreatic enzyme which apparently does little harm to the
body, namely, serum amylase. It
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has been shown that under certain
conditions the measurement of urinary amylase output-and I emphasize output per unit time, not
merely amylase concentration in
the urine in a spot sample-may be
increased when serum amylases are
normal. One cannot say categorically whether measurement of
serum or urinary amylase output
is better, but if a patient is seen
with abdominal pains, and the overall clinical picture includes one or
more of the conditions so frequently associated with pancreatitis,
serial tests of both serum amylase
concentration and of urinary amylase output before, immediately
after, and days after the attack are
the most successful laboratory
means available to us, at present, for
recognizing pancreatitis (Gambill
and Mason, 1963).
Methods for measuring amylase
in body fluids are, in addition, becoming more discriminatory. By appropriate electrophoretic and chromatographic techniques, amylases
of salivary and pancreatic origin
may be distinguishable both in the
urine and in the serum. Thus, a
recent English article has indicated
that decreased output of urinary
amylase may be found in patients
with chronic pancreatitis, provided
salivary amylase is separated from
pancreatic amylase (Aw, Hobbs,
and Wootan, 1967). The total urinary amylase in such patients, the
authors claim , may be normal, but
a decreased proportion contributed
by the pancreas may be masked by
a corresponding increase in salivary
amylase.
Other studies, such as those
which have appeared recently in

perhaps, even liver-will be identifiable.
Pending the development of sophisticated techniques that are less
cumbersome and more reliable, the
diagnosis of pancreatitis will continue to depend on amylase determinations, especially those carried
out serially.
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Cirrhosis: What Is It?*
CHARLES M. CARAVATl

Department of Medicine, Medical College of Virginia
Richmond 23219

"For the King of Babylon stood
at the parting of the way, at the
head of the two ways, to use divination: he made his arrows bright,
he consulted with images, he
looked in the liver." Ezekiel 21.
The liver has been looked upon by
primitive man as the probable
source of health, disease and even
of evil spirits, and in 304 B.C.
Erasistratus recognized that there
was an association between ascites
and liver disease. In 1689 John
Browne described it as hardening
of the liver, and Bailly noted its relation to alcohol in 1793. Then, in
1819, Laennec called it cirrhosis
after the Greek word kiros, meaning orange or yellow. Of interest, I
believe, is a picture found in Life
magazine about ten years ago. It
is of a tombstone dated 1790 in a
New Hampshire graveyard, the
tombstone of a man from whose
peritoneal cavity was drawn 2,385
pounds of water. Unquestionably
he had cirrhosis.
Defl nit ion of Cirrhosis
A proper definition of cirrhosis
is difficult, but for this discussion
I think the following probably
serves our purpose: It is a chronic
liver disease characterized by destruction of cells, by the formation
of new tissue- particularly connective-and by diffuse regeneration.
No effort will be made to offer a
classification, because one cannot
be found which satisfies the criteria
we would like to discuss.

* Presented at the Thirty-Ninth
Annual McGuire Lecture Series, November 9-10, 1967, Medical College
of Virginia, Richmond.
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Distribution of Cirrhosis
I would now like to talk about
the extent and the implications of
the disease itself. The first thing
I think we ought to note is that
cirrhosis is global-very wide~
spread. About a third of a million
people die every year from cirrhosis of the liver; it is the eighth cause
of death, and in the age group
from 45 to 64, it is surpassed only
by cardiovascular .and neoplastic
disease. It has a very interesting
distribution. For instance, in
France there are 26 deaths per
hundred thousand population; but
in England, just across the Channel, there are only two per hundred thousand. In Virginia there
are 7.7 deaths per hundred thousand; in New York there are 19.
We reviewed the vital statistics of
Virginia for five years, 1960-1964,
and there were 1,545 deaths,
about equally divided between
whites and non-whites, with males
predominating, and with the average age being from 48 to 50. The
records at MCV from 1960-1963
showed 94 cases diagnosed as cirrhosis, but could confirm only 44.
In reviewing the problem of cirrhosis in any area, one is impressed
with its probable association with
alcohol. By extrapolation, it is accurate to state that more than
50 % of cases of cirrhosis are associated with excessive consumption
of alcohol. In the Virginia Vital
Statistics 33 % of the death certificates indicated that alcohol was a
probable factor. The Mayo Clinic
report of 1950 on a five-year study
indicated there was an alcoholic
history in 64% of their patients.
In Los Angeles in 1953, of 16,000
MCV QUARTERLY 4(1): 10-17, 1968
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autopsies there were 782 cases of
cirrhosis, and 7 8 % of these were
reported as heavy drinkers. A report from Minneapolis over 20
years ago reported that only 25 %
of their cirrhotics were associated
with alcohol, but I call your attention to the fact that there were
only 100 cases studied. It is important to consider that only one
alcoholic in 12 develops cirrhosis.
What happens to the other 11?
Why do they not develop cirrhosis? At this time the answer is not
available.

Etiology of Cirrhosis

Actually this chronic liver disease probably starts as an acute
insult to the liver, to the hepatocyte itself, and to the mesenchymal
cells; and then a reaction develops,
probably associated with ischemia.
The pathological states that are
most responsible for this injury are
steatosis, necrosis, cholestasis, and
hypoxia. In chronic liver disease
these processes are perpetuated by
persistence of an original offender
such as piecemeal necrosis, which
is probably the most important
factor in the production of cirrhosis. In the proximity of these dead
cells, there are immunoglobulincontaining cells-mesenchymal
cells-which may assist in the perpetuation of this reaction. A hypersensitivity reaction may be an
important factor in the continuance of the inflammatory reaction,
but no circulating antibodies to the
hepatocyte have been demonstrated,
although antibodies to nuclear
DNA, as well as to proliferating
bile ducts, have been demonstrated.
Disturbances in the hepatic circulation must be an important factor
in the perpetuation of cirrhosis.
These may be most profound. The
most striking change, which can
be demonstrated clearly by utilizing injection techniques, consists
of marked distortion of the hepatic
vasculature with pronounced dis-

in three of these individuals at the
end of 18 months, and all five
probably had viral hepatitis. There
are now other histological reports
available showing progression from
viral hepatitis to definite cirrhosis.
However, Franken et al. ( 1967)
reexamined 154 patients some
years after they had had clinical
hepatitis. Thirty-three showed some
abnormal biochemical changes, but
only three were found to have cirrhosis, and they were alcoholics.

turbance of the venous outflow tract
and post-sinusoidal obstruction.
Hepatitis

There are certain clinical disorders that may be etiological factors in liver disease. Let us consider some of these. How big a
factor is hepatitis? It is very difficult to document that a patient
with primary viral hepatitis develops cirrhosis. He probably does,
but actually one has to have biopsy
studies over a period of time to
prove this. The same thing may
be said about ethanol, malnutrition, and others. Schaefer et al., in
March of 1967, reported on five
individuals with viral hepatitis on
whom they performed punch biopsies; these individuals presented
a characteristic picture of acute
hepatitis with necrosis, inflammation, distortion, and many different types of cells. In biopsies
taken some months after the onset,
they found fairly normal liver cells
without radial pattern and widened
scarring with many lymphoid cells,
which is a characteristic picture
of post-necrotic cirrhosis. In this series, quiescent cirrhosis was found

Malnutrition

What is the role of malnutrition?
Malnutrition's role is not clearly
understood. It is thought now that
it plays a much smaller role than
formerly believed (Jolliffe and Jellinek, 1941). There are few nutritional states in which cirrhosis is
common; one of these is chronic
ulcerative colitis, in which liver
pathology occurs and cirrhosis may
develop (Palmer et al., 1964) .
There are other nutritional disorders in which people do not develop cirrhosis. For instance, in
the patient with kwashiorkor, a
disease caused by protein deficiency,
why is it that the patient does not
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Fig. I-Liver pathology and organ systems affected by cirrhosis.
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develop cirrhosis (Scrimshaw et al.,
1959)? A marked fatty liver is
very common in this disorder, but
it never develops cirrhosis. It is not
known why, but it is clear that
some fatty livers may be followed
by typical "nutritional" cirrhosis,
whereas others may not.
Stasis

Stasis, especially that caused by
extrahepatic obstruction resulting
from benign disorders such as
common duct stones, causes cholangitis. This, in turn, may result
in cirrhosis of the biliary type, but
biliary cirrhosis may be found in
the absence of extrabiliary obstruction.
Alcohol

Now what about alcohol? What
does alcohol do to the liver? Does
it produce a toxic or a metabolic
effect? Alcohol can produce a definite direct effect on the hepatic
parenchyma. It is not necessary,
also, to have malnutrition or the
lack of any substance, for alcohol
per se is toxic to liver cells. Alcohol may cause a type of hepatitis
with necrosis, inflammation, cholestasis, deposition of hyalin; and
all these pathological abnormalities

TABLE 1
Changes in Skin and
Musculoskeletal System
Icterus
Pellagra-Like Changes
Palmar Erythema
Nails: Flat. Terry. Bluish.
Muscle Wasting
Alopecia
Xanthomata
Pruritis
Dupuytren's Contracture
Osteoarthropathy
Dilated Veins
Spider Nevi
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may be factors that result in cirrhosis. The steatosis associated with
alcoholism may predispose the liver
to cirrhosis; at least fatty changes
often precede the deposition of
fibrous tissue. Does steatosis really
cause cirrhosis, and, if so, how does
it do it? The work of Leevy ( 1962)
suggests that the fatty liver seen in
alcoholics often progresses to cirrhosis, and fat per se may be an
important etiological factor in the
production of cirrhosis. Hartroft
and Ridout (1954) are in agreement with this view. However,
some authors, such as Popper,
Szanto, and Elias (1955), doubt the
role of steatosis as an etiologic
agent in cirrhosis but feel strongly
that the necrosis of cells produced
by alcohol initiates the changes
which lead to cirrhosis.
Drugs

While drugs and chemical agents
frequently cause liver injury and
even death, their use seldom ends
in cirrhosis. This is difficult to explain, because the original injury
may be indistinguishable from viral
hepatitis.
Pathophysiological Disturbances

When cirrhosis occurs, there are
multi-system pathophysiological
disturbances, which at times are
very pronounced. We will discuss
a few of the important extrahepatic
changes occurring in individuals
with cirrhosis. In Figure 1 the chief
hepatic alterations are listed within
the circle; the organ systems which
may be functionally and structurally affected by the liver pathology are indicated outside the circle.
Changes in skin and
musculoskeletal system
First, let us consider the skin
and musculoskeletal system (Table 1). Beginning with the fingers,
there is often clubbing of the nails,
the so-called Terry nails or the blue
nails of Wilson's disease (Kleeberg, 195Jl; Terry, 1954; Morey,

1955) . There is often marked muscle wasting and the characteristic
alopecia, as well as Dupuytren's
contracture, which Wolfe, Summerskill, and Davidson ( 1956) state
occurs in two-thirds of the people
with cirrhosis but, in our experience, is not seen as frequently.
Even though Hijams van den
Bergh in 1901 described pulmonary osteoarthropathy in a patient
with cirrhosis and cyanosis, little
emphasis has been placed on it.
Recently, however, we have seen
several such patients, and each
showed low arterial oxygen saturation, which was first reported by
Snell ( 1935) . Hansoti and Shah
in 1966 reported that one out of
seven cases of cirrhosis seen by
them in India showed osteoarthropathy. Figure 2 shows a clear
x-ray picture of subperiosteal thickening of the tibia characteristic of
osteoarthropathy in an individual
who has severe cirrhosis. Such osteal changes may be seen quite
frequently, if radiological examination of the bones is performed on
cirrhotics.
The spider nevus, which is like
a coiled end artery raised on the
skin with a central pulsating hub
from which many divisions of the
vessels divide, is actually a vein-like
vessel but contains arterial blood.
There may be a pressure ranging
from 60 to 100 mm Hg in these
"spiders." According to Bean
(1945), "spiders" can be seen in
about 60 % of cirrhotics. Why do
these angiomas occur in portions
of the body supplied by the superior caval vessels? Occasionally
they occur in other areas such as
the legs, but very rarely, and almost as rarely on the forearms or
hands.
Changes in circulatory system

The cardiovascular changes are
among the most striking seen in
cir,rhosis. Some of the more common are listed below.
1. Gross distortion of hepatic
vasculature;
2. Portal hypertension.
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3.
4.
5.
6.
7.
8.
9.
10.
11.

Venous anastomoses.
Multiple A-V fistulae.
Tachycardia.
Increased aortic blood flow.
Low arterial oxygen saturation.
Increased cardiac output.
Short circulation time.
Low peripheral vascular resistance.
Reduced arterial hypertension with varices.

A hyperdynamic cardiovascular
system is manifested by many
changes. Many of these are due to
multiple A-V shunts that occur in
the lungs and pleurae, as well as
in the liver, with venous admixture
and arterial unsaturation (Hecker
and Sherlock, 1956) . Heart failure may occur, particularly after
surgical shunts.
Schwartz ( 1967) has recently
shown that arterial hypertension is
rare in cirrhotics, unless it is associated with renal disease. But if
those patients who have renal disease and also have arterial hypertension and cirrhosis develop
varices, then the arterial blood
pressure becomes normal. If one
does an end-to-side shunt on those
individuals, the blood pressure goes

back again. What does this mean?
Is there some substance inhibitory
to the hepatic angiotensinase that
is diverted from the liver in patients with varices?

presence of acanthocytes (Douglass, McCall, and Frenkel, 1968).
There is quite frequently an excess of fibrinolysins, according to
Ratnoff ( 1963) .

Changes in hemato poietic system

Changes in renal system

The hematological changes occurring in the cirrhotic are many
(Table 2) . There is frequently a
quantitative diminution in platelets, as well as changes in platelet
aggregation (Thomas, Ream, and
Stuart, 1967), and, at times, thrombasthenia (Mandel and Lazerson,
1961). Further, there may be significant abnormalities in the red
and white cell in the presence of
anemia and leukopenia or even
leukocytosis. There may be folic
acid deficiency due to faulty storage (Herbert, Zalusky, and Davidson, 1963), as well as production
defects such as a deficit in fibrinogen and prothrombin (Ratnoff,
1963). Production of abnormal
complexes, such as the macroglobulins-notably the 7-S macroglobulin-is not infrequent, and
recently deficiency in immunoglobulin A has been reported (Wilson
et al., 1968). Hemolysis is not uncommon and may be related to the

One of the most important functional derangements is the renal
change, the so-called hepato-renal
syndrome. Many patients who have
advanced cirrhosis die in hepatic
failure without any significant disease of the kidney. While specific
renal abnormalities which cause
renal failure are occasionally demonstrated (Laube, Norris, and Robbins, 1967), they are quite rare.
A study in Boston by Garceau and
Chalmers (1962) of 253 cases of
patients with varices who had died
revealed that renal shutdown preceded death in 11 % . of the cases.
The pathophysiology of the hepatorenal syndrome is still unclear,
though reduced glomerular filtration may be one of the mechanisms
responsible for the renal failure.
There is significant reduction in
maximum urine concentration and
the rate of solute-free water reabsorption in cirrhosis. This is reversible if hepatic compensation
improves (Vaamonde et al., 1967) .
Changes in endocrine system

The endocrine features shown
below are but a few encountered.
1.
2.
3.
4.
5.

Fig. 2-Radiological appearance of the periosteum showing marked thickening
seen frequently in cirrhosis.
· ·

Gynecomastia.
Hyperestrogenism.
Hyperaldosteronism.
Amenorrhea.
Gonadal atrophy.

Gynecomastia may be marked,
and such breast changes, as we.11
as testicular atrophy, are thought
to be due to the inability of the
liver to conjugate estrogen (Pincus et al., 1951 ; Morrione, 1944).
The most important feature in the
management of patients is the increase in serum aldosterone. If
one gives 500 mg of aldosterone to
a patient with ascites, he will excrete about 15 % of this mass. If
the same .load is given to a normal
' 13

CIRRHOSIS: WHAT IS IT?

individual, he will excrete about
5 % of aldosterone. This indicates

that the liver is not degradating
the aldosterone delivered to it,
and, therefore, more of it is going
to the kidney. As a consequence,
there is more sodium retention.
Amenorrhea was reported by
Armas-Cruz (1951) in 39 of 66
females, and testicular atrophy
was found by Morrione in 90%
of males under the age of 50
( 1944) .
Changes in nervous system

Below are some of the central
nervous abnormalities that may be
seen in advanced cirrhosis.
1.
2.
3.
4.

5.
6.
7.
8.

Encephalopathy.
Asterixis.
Variable reflexes.
Coma.
Convulsions.
Hemiplegia.
EEG.
Polyneuritis.

Drowsiness and asterixis are
common, as are stupor and coma.
Convulsions also are not unusual.
In fact, one may find any type of
encephalopathy associated with hepatic failure. Reflexes may change
frequently. For instance, one may
get a positive Babinski in the morning, and in the afternoon the Babinski may disappear. The electroencephalogram may be helpful in
differentiating hepatic decompensation from other types of encephalopathy, but the patterns are often
non-specific. While at autopsy the
brain sometimes shows an increase
of astrocytes, there is really no
known specific brain lesion that
causes the encephalopathy. Peripheral neuritis with hyperesthesia, including pain, is often seen and
is thought to be caused by the direct effect of ethanol and/ or malnutrition.
Changes in pulmonary system

Hydrothorax is one of the more
frequent chest findings in chronic
liver disease. It occurs in 5 % to
10% of people who have ascites.
It is caused by the ascitic fluid
14

filtering directly through the diaphragm into the right hemothorax.
Occasionally one will see hemothorax, probably as a result of the
bleeding tendencies such patients
develop (Christian, 1927; Meigs,
1954). There are often arteriovenous fistulae in the lungs and
pleurae.
Changes in gastrointestinal system

Abnormalities in the gastrointestinal tract are many, as noted in
Table 3. Varices of the esophagus
and stomach with portal hypertension may be considered almost a
part of the disease. Splenomegaly
is evident in about 50% of cases
(Ratnoff and Patek, 1942). Peptic
ulcer is more common than in
normal individuals, and its incidence is increased even more after
shunt surgery (Lipp and Lipsitz,
1952; Patek, 1963). Fetor hepaticus, which in the past was frequently encountered and which
indicates liver decompensation, is
now quite rare (Challenger and
Walshe, 1955). This clinical finding
may be less because of the frequent
administration of such antibiotics
as neomycin in the management of
the disorder.
Ascites, a peritoneal transudate,
is a hallmark of cirrhosis with
which we are all familiar. We will
not go into the mechanisms involved. Recently two types of
peritonitis in cirrhotics have been
reported, one caused by pneumococci (Epstein, Calia, and Gabuzda, 1968) and the other by
enteric organisms (Conn, 1964),
the diagnosis being made by culture of ascitic fluid. Pancreatitis is
found clinically in about 5 % of
cirrhotics, according to Lipp and
Lipsitz (1952).
Hepatoma is a rather common
complication of cirrhosis, especially
of the post-necrotic type. Recent
studies by Alpert, Wogan and
Davidson (unpublished data) in
Uganda have demonstrated that
certain fungal toxins, particularly
aflatoxins from the aspergillae,
may cause cirrhosis and hepatoma
in animals. These aflatoxins are

TABLE 2
Changes in Hematopoietic
System
Faulty Storage
Destruction
Production Defect-(ProthrombinFibrinogen)
Blood Loss
Production of Abnormal
Complexes (Macroglobulins)
Poor Absorption
Anemia
Leukopenia. Leukocytosis
Thrombocytopenia- Platelet
Aggregation
Clotting Defects
Folic Acid Deficiency
Acanthocytes
L. E. Cells

Fibrinolysins
Immunoglobulin A Deficiency

TABLE 3
Changes in Gastrointestinal
System
Fetor Hepaticus
Varices
Ascites
Pancreatitis
Splenomegaly
Abdominal Hernia
Peritonitis: Spontaneous.
Pnepmococcic.
Peptic Ulcer
Hepa tom a
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found in the soil and in certain
foods such as ground nuts. This
brings up the important questions:
Are there other toxins that may
produce cirrhosis and hepatoma?
Is fungal toxin, for instance, present in alcohol itself, and is this
the factor that causes its toxic effect on the liver? Some recent
work suggests this. One of the most
interesting studies on hepatoma is
by Lee in England (1966) . In
this study he reviewed a large
group of alcoholic patients, all of
whom had a finely granular type
of cirrhosis. When these patients
stopped drinking, within five or
six months, according to his study,
they developed very large nodules
in the liver, a nodular type of cirrhosis; 16 (55%) of the 29 individuals who gave up drinking developed hepatoma, but only 9
(16%) of the 56 who continued
to drink developed hepatoma. It
was of interest that fewer females
had hepatomas, but at the same
time a much smaller percentage of
women discontinued alcohol. We
have recently seen advanced postnecrotic cirrhosis with very large
nodules in which a transition from
benign to malignant cells is clearly
evident. Why neoplasia develops
in this type of environment is still
unclear (Parker, 1957; Kay, 1964;
Miyai and Reubner, 1963).

cially in the gamma fractions, is
frequently seen in chronic liver disease, and probably more often in
post-necrotic cirrhosis. Hypoglycemia may occur in severe liver
disease, as the liver is depleted of
glycogen. It may also occur in hepatoma, but the cause of it is still
unclear. Hypoalbuminemia with
values below 2 mg/ 100 ml is not
unusual in advanced chronic liver
disease. This plays an important
role in the fluid retention so often
observed.

with concomitant portal hypertension, although the patient may have
no subjective symptoms. Rolleston
and McNee (1929), in a study of
167 postmortem examinations of
cirrhotics, noted that 87 of these
had had minimal or no symptoms.
McCartney (1933) found no evidence that the patient had symptoms in 35 % of individuals who
died with cirrhosis.

Changes in temperature regulation
Continued low-grade fever is not
too rare, and, while cirrhosis predisposes to many types of infection, it is now known that the
hepatic pathology itself may produce a febrile response (Tisdale
and Klatskin, 1960). In animals an
hepatic pyrogen has been isolated,
and it is likely that in some instances in humans the damaged
liver releases a pyrogen capable of
inciting fever in the host. In animals this hepatic pyrogen is easily
extractable and may be suppressed
by glucocorticoids.
Of 80 patients studied by Klatskin and Tisdale, 58 had unexplained fever. It was concluded
that this was probably a reflection
of the diseased liver and not a result of any other complications.

An effort has been made to
present a panoramic view of cirrhosis. It has been indicated that
many agents may initiate an intrahepatic process which may progress to advanced cirrhosis, that
the characteristic abnormalities may
cause both functional and pathologic multi-system changes, and
that these encompass almost every
body structure. As the altered structural and physiological changes
progress, hepatic decompensation
develops, and this often is terminal.

Changes in blood chemistry

Miscellaneous changes

Abnormal blood chemical findings are frequently seen, and hyperlipemia is one of the more common, especially in biliary cirrhosis.
Hyponatremia is almost the rule
in the decompensated ascitic, in
spite of the fact that the individual has increased body sodium;
when the sodium level is 125 mM
or below, it may be a poor prognostic sign (Hecker and Sherlock,
1956; Eisenmenger et al., 1950;
Pecikyan, Kanzaki, and Berger,
1967; Galambos and Wilkinson,
1962). Hypomagnesemia may be
found in the advanced cirrhotic and
may be responsible for some of the
encephalopathies that occur. A
marked increase in globulins, espe-

One rather commonly observed
finding is parotitis. There is no specificity to the pathological changes
found in the parotid glands. The
glands are usually bilaterally enlarged, firm and rubbery, and are
probably more commonly seen in
cirrhotics associated with alcoholism (Ratnoff and Patek, 1942; Patek, 1963).
Unexplained abdominal pain
may be present in patients with
uncomplicated cirrhosis. At times
it may be quite severe. Several
authorities have observed that it is
more commonly found in patients
who have concomitant ascites.
It should be emphasized that
advanced cirrhosis may be present

Summary
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The Relation of the Intestinal Cell Surface
to Vitamin 812 Absorption*
ROBERT M. DONALDSON, JR.

Department of Medicine, Boston University School of Medicine,
Massachusetts 02118

I appreciate the opportunity to
join in this symposium and be here
in Richmond. You are learning today that small bowel function can
now be studied in many different
ways, but during this presentation
I would ask you to restrict your attention to events occurring right at
the absorptive surface of the intestinal cell. There are valid reasons
for taking such a narrow view. To
be absorbed by the small bowel,
any nutrient must traverse the
membranous structure which lines
the absorptive surface of the intestinal epithelial cells, and, thus,
all absorptive mechanisms depend
upon the characteristics of this surface membrane. You have seen how
the intestinal mucosa is thrown into
fingerlike projections called villi,
and Dr. Sessions showed some elegant movies of the movement of
these villi. You should recognize
that the surface of the individual
cells lining these villi is further increased by tiny projections known
as microvilli. The microvilli consist
of a trilaminar unit membrane and
a central core of proteinaceous filaments which extend into the cytoplasm and unite to form a terminal
web. Lying on the outer surface of
the membrane is a mucopolysaccharide surface coat or fuzz. Ito
(1965) has shown that this surface
coat is not extraneous mucous but
represents an integral part of the
absorptive cell.

*Presented at the Thirty-Ninth
Annual McGuire Lecture Series, November 9-10, 1967, Medical College
of Virginia, Richmond.
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The brush border area of the cell
consists of microvilli, terminal web,
and a small portion of apical cytoplasm. When intestinal cells are
ruptured according to the method
of Miller and Crane (1961), this
portion of the cell can be isolated
by repeated centrifugation. Brush
borders can then be further disrupted to yield a relatively pure
preparation of microvillous membranes separated out by density
gradient centrifugation (Eichholz
and Crane, 1965). Since it is now
possible to examine brush borders
and microvillous membranes separately from the rest of the intestinal cell, it is safe to predict that
you will be bearing more and more
about the composition and function
of these surface structures. In fact,
considerable information is already
available concerning this "absorpti ve-d igesti ve" surface .. Alkaline
phosphatase activity has been localized to the brush border area by
many workers and to the microvillous membrane by Eichholz (1967).
Ito ( 1965) has shown alkaline
phosphatase activity in the fuzzy
surface coat by histochemical techniques adapted for the electron
microscope. Adenosine triphosphatase activity is also present in brush
borders. Various disaccharidases
which digest sucrose, maltose, and
lactose to yield their constituent
monosaccharides are located at the
surface of the intestinal cell. Miller
and Crane (1961) demonstrated
them in brush border preparations,
Eichholz ( 1967) subsequently
showed these sugar-splitting enzymes to be more precisely located
MCV QUARTERLY 4(1): 18-20, 1968
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in microvillous membranes, and
Johnson ( 1966) has more recently
suggested their location at the
fuzzy surface coat. Leucine aminopeptidase and cholesterol este;: hydrolase are found in the brush
border of absorptive cells. In terms
of function, McDougal and others
in Crane's laboratory (1960)
showed that isolated brush borders
actively transport glucose against
the concentration gradient. We have
recently demonstrated an intrinsic
factor-mediated attachment of Vitamin B12 to intestinal brush borders
and microvillous membranes (Donaldson, MacKenzie, and Trier,
1967; MacKenzie et al., 1967) .
The work will be described in some
detail as an illustration of the
kinds of information to be obtained from an examination of
these surface structures.
Precisely how intrinsic factor
(IF) promotes Vitamin B12 absorption is not known, but it is
now clear in all species studied that
intrinsic factor, to be effective, must
first bind the vitamin in a macromolecular complex. Furthermore,
IF-dependent B1 2 absorption occurs
predominantly from distal rather
than proximal portions of the intestine. In man, for example, it is
generally accepted that the terminal
ileum is the major site for B12 absorption. These observations suggest that a specific binding site or
receptor for the IF-vitamin B1 2
complex may be present on the
surface of ileal absorptive cells. To
investigate this problem, we incubated radioactive Vitamin B12 with
brush borders and microvillous
membranes isolated from either the
proximal or distal half of hamster
small bowel.
Each of these preparations was
isolated from either the proximal
or distal half of hamster intestine.
Hamster gastric juice served as the
source of intrinsic factor. When
these preparations were obtained
from the proximal half of hamster
intestine, IF regularly depressed
rather than enhanced B12 uptake.
On the other hand, IF regularly

enhanced uptake when these preparations were taken from the distal
half of the intestine. Specific uptake in terms of picograms B12
per milligram of tissue nitrogen is
much greater for microvillous membranes than for brush borders or
mucosa! homogenates. These observations directly demonstrate intrinsic factor acting at the absorptive surface of distal but not
proximal intestine. The IF-mediated attachment to membrane occurs rapidly, is not increased with
prolonged incubation, is not affected by temperature changes from
7° to 37 ° C., and does not require
glucose or oxygen. These findings
are consistent with a physical adsorption of the IF-B 12 complex onto
the membrane rather than with any
energy-requiring enzymatic process.
This physical attachment is very
specific, however, since only hamster and rat intrinsic factor stimulate B1 2 uptake by hamster brush
borders. Intrinsic factor from hog,
dog, rabbit, guinea pig, and man
are all ineffective. Vitamin B12
binders present in serum, saliva, or
tissue extract which do not contain
intrinsic factor activity fail to promote attachment. Uptake is maximal only when all of the B1 2 in
the incubating medium is bound
in a macromolecular complex with
hamster intrinsic factor. Thus, the
binding site on the hamster intestinal membrane shows considerable
specificity for this IF-B 12 complex.
It seemed to us that if a specific
receptor to the IF-B 12 complex did
indeed reside on the very surface of
the intestinal cell, then it might be
possible to make an antibody to
such a receptor. Thus, we injected
into rabbits pure preparations of
microvillous membranes obtained
from either the proximal or distal
half of hamster intestine (Mackenzie et al., 1967). When brush
borders were incuhated with normal
rabbit serum, IF-mediated attachment of B12 proceeded normally.
However, when these brush borders
were first incubated with antisera to
distal microvillous membranes, the

effect of intrinsic factor was completely and regularly blocked. On
the other hand, serum from rabbits
injected with proximal microvillous membranes was not inhibitory.
Thus, distal, but not proximal microvillous membranes, contained
something which induced in rabbits a serum inhibitor to the attachment of the IF-B 12 complex to the
surface of hamster intestine.
Antisera to distal microvillous
membranes capable of inhibiting
IF-mediated uptake contain no antibodies against intrinsic factor itself or against the IF-B12 complex
as determined by three different
methods. Furthermore, the inhibitory factor could be absorbed from
antisera by distal brush borders but
not proximal brush borders or by
intrinsic factor. These findings are
consistent with the. idea that distal
microvillous membranes induced an
antibody directed against the intestinal receptor for the IF-B 1 2
complex.
To determine the nature of the
observed inhibition, we incubated
increasing quantities of IF-B 12 with
brush borders in the presence of
either normal rabbit serum or antiserum to distal microvillous membranes. The results showed that the
inhibitory factor could be overcome
by an excess of IF-B 12 and suggested that inhibition is competitive.
Presumably the inhibitory factor
competes with IF-B 12 complex for
a common binding site or receptor
on the microvillous membrane.
Several lines of evidence suggest
that this inhibitory factor is an
antibody. First, it was produced in
serum by injecting a foreign substance into rabbits. In addition,
chromatography identified the inhibitory factor as an immunoglobuIin. When rabbit antiserum was
eluted from a Sephadex G-200 column, the usual three protein peaks
were obtained. When these. peak
fractions were tested for inhibitory
activity, only the second 7S globulin
peak produced significant inhibition.
Chromatography on diethylaminoethyl-cellulose and immunoelectro19
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phoresis confirmed that immunoglobulin G contained the inhibitory
factor. I have indicated thus far
that distal, but not proximal microvil1ous membranes induce an antibody against the intestinal binding
site for the IF-B12 complex and
that this inhibiting antibody can be
absorbed by distal, but not proximal brush borders.
We wondered whether proximal
and distal microvillous membranes
could induce the formation of other
antibodies and, if so, whether crossreactions between proximal and
distal would occur. Double diffusion in agarose gel shows distinct
precipitin lines when antibodies to
proximal and distal microvillous
membranes are tested against brush
border extracts from the distal and
proximal halves of the intestine.
Under these conditions, cross-reactions between proximal and distal
tissues occur. Thus, both proximal
and distal microvillous membranes
contain similar antigens, but only
distal microvillous membranes
contain an antigen capable of producing the inhibitory factor. In order to locate the site of antibody
attachment to the intestinal cell,
we stained hamster intestine either
with fluorescein-labelled normal
rabbit serum or with fluorescent
antiserum to microvillous membranes. Fluorescent antiserum was
clearly localized only in the brush
border area of the intestinal cell.
More precise localization of the
site of the antigen-antibody reaction was attempted. Immunoglobulin G from control rabbits and from
rabbits injected with microvillous
membranes was conjugated with
ferritin, and the ferritin-labelled
antibodies were incubated with
hamster intestine. The location of
ferritin particles was then identified
with the electron microscope by
Dr. Jerry Trier.
Numerous dense ferritin particles were localized to the fuzzy
mucopolysaccharide surface coat
of the microvilli but not to the unit
membrane itself. This localiza_tion
is not surprising when one consid20

ers the fact that, in general, mucopolysaccharides are potent antigens. This observation raises the
possibility but does not provide evidence that the inhibitory factor in
rabbit antisera may also localize to
the fuzzy surface coat. At present
we are investigating this possibility,
since, using immunologic techniques, we should now be able to
distinguish whether the intestinal
receptor for IF-B12 is situated on the
mucopolysaccharide surface coat.
I have tried to indicate that it is
now possible to separate out events
occurring at the surface of intestinal absorptive cells. Previous work
has shown that intestinal brush
borders contain diverse enzymatic
activity and that the surface of the
intestinal cell is a site for active
glucose accumulation. Futhermore,
brush border and microvillous
membrane preparations now provide direct evidence that intrinsic
factor acts at the intestinal cell surface. These studies directly support
the concept that a specific receptor
for the IF-B 12 complex is located
on the surface of ilea!, but not jejuna! absorptive cells. Studies with
antibodies against pure preparations of microvillous membranes
verify the existence of this receptor
and provide ari approach to its
further localization and characterization.
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Amino-Acid Absorption*
BERTRAM FLESHLER

Case Western Reserve University School of Medicine,
Cleveland, Ohio 44106

Most, if not all, ingested protein is transported across the gut as
its constituent amino acids. Thus,
the way the gut handles amino
acids is an important physiologic
problem, and their mishandling by
the gut in disease states represents
an important threat to general
body activities. I propose to discuss some of the knowledge that
has been gathered over the past
10 to 15 years concerning the
mechanisms of amino acid absorption. The data to be presented have been gathered from
three major kinds of studies: the
studies of in vitro model systems,
physiologic studies of humans, and
studies of patients , with syndromes
involving specific amino absorption
abnormalities. Some of these data
have been accumulated in our own
laboratory; much of what I have
to present is the work of other
investigators.
In Vitro Studies on Gut
Figure 1 shows an experimental
technique which has become a
classic model for the study of
transport of various substances,
not only amino acids. This is the
everted gut sac. The technique involves making everted gut segments from the intestines of small
animals. The animal's gut is removed as quickly as possible,
cleaned, turned inside out so that
the mucosa is on the outside, and
small sacs made of the segments

* Presented at the Thirty-Ninth
Annual McGuire Lecture Series, November 9-10, 1967, Medical College
of Virginia, Richmond.
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of the gut. The sacs are then placed
in various bathing solutions containing the substances to be tested.
Figure 2 shows the kinds of results one can obtain with this kind
of method. As indicated by the
dotted line, the concentration of
the substance tested, in this case
the amino acid, L-tryptophan, was
the same on both the mucosa! and
the serosal sides. The measurement
of the concentration changes at
various time intervals following the
placing of the substance in the sac
is an indication of what movement
is going on. Under aerobic conditions (the box on the left), the
mucosa! concentration of tryptophan (black column) decreased
after an hour's incubation, and the
serosal concentration increased.
Remember that the initial concentration was the same on both sides.
Anaerobically, when oxygen was
not allowed in the flask, concentration against a gradient no longer
occurred.
The importance of aerobic,
energy-dependent systems for
transport of L-tryptophan from the
mucosa! surface to the serosal side
is shown in Figure 3. In this study,
tryptophan initially was placed
only on the mucosa! side, in contrast to the previous study. None
was on the serosal side. After an
hour's incubation aerobically, not
only had some tryptophan been
transported from the mucosa! to
the serosal side, but there also
now existed a concentration gradient between these two sides. By
contrast, anaerobically the transfer from the mucosa! to serosal
side was very much diminished,

and no concentration gradient had
been developed.
Figure 4 shows an experiment
with a substance for which there
is no active transport mechanism.
The test substance was pyridoxine.
In the upper bar is shown the
situation when pyridoxine was
placed at equal concentration on
both sides of the everted gut sac.
There was no concentration gradient developed from the mucosa to
serosa either aerobically or anaerobically. The bottom set shows the
situation when the pyridoxine was
placed only on the mucosa! side.
Transfer was slow; no concentration gradient developed, and it did
not make any difference whether
the environment was anaerobic or
aerobic. This further confirms the
idea that energy-dependent systems
are of significance in transporting
tryptophan, whereas they are not of
significance in transporting pyridoxine.
By the use of this in vitro technique, unphysiologic as it may
sound, much information has been
gathered as to the transport of
amino acids. Table 1 shows some
data obtained with a series of
amino acids using the everted gut
sac technique. A concentration
gradient > 1.00, as indicated in the
third column, indicates that there
was accumulation of these amino
acids on the serosal side as compared to the mucosa! · side, the
amino acids having been in each
instance placed in equal concentrations on both sides of the membrane at the start of the experiment.
It is obvious that different amino
acids behave in somewhat different
21
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manners. In addition to testing
single amino acids, mixtures of
amino acids and amino acids in
which parts of the amino acid molecules have been modified have also
been studied.
On the basis of such studies in
the everted gut sac, it appears that
certain types of amino acids are
transported by specific mechanisms. It is presently thought that
there exist separate specific transport mechanisms for the monocarboxylic neutral amino acids; for
dibasic amino acids, such as lysine,
arginine, and ornithine along with
the neutral amino acid, cystine; for
the dicarboxylic amino acids; and,
possibly, for proline, hydroxyproline and, questionably, glycine.
Figure 5 shows a sketch of how
amino acids might interact with
a membrane carrier. This scheme
applies, most likely, to the neutral
amino acids. The carboxyl, the
hydrogen, and the alpha amino
groups all are quite specific, since
substitutions at any one of these
sites decrease the transport rate of
the amino acid. The question mark
next to the pyridoxal phosphate indicates that certain studies suggest
that this substance may be an important co-factor in neutral amino
acid transport. The longer the side
group, indicated here as the R, the
more lipophilic the substance is
and the greater the affinity of the
amino acid for the lipid carrier or
the lipid membrane. It has been
shown in the group of neutral
amino acids that those with a
longer side chain, i.e., those with
a more lipophilic side chain, compete preferentially for transport
with those with shorter side chains.
Thus, on the basis of these animal in vitro experiments, of which
this has been only a brief resume,
there has evolved a concept of
amino acid absorption as being
one in which there are several
specific carrier mechanisms involved.
Studies o n Human Gut
In order to study amino acid absorption in humans, different tech22

Fig. 1-Everted sac method of Wilson and Wiseman. Tied sac of everted
hamster jejunum containing 1 ml of fluid. X 2.64 (Reprinted with permission
from T. H. Wilson, Intestinal Absorption. Philadelphia: W. B. Saunders, 1962,
p. 33.)
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Fig. 2-Transport of SH-labelled L-tryptophan by everted loops of rat small
intestine. The interrupted line indicates initial concentration on both sides of
the sac. The final concentrations in each of two experiments are shown by the
columns. Note that at the end of one hour there· is a concentration gradient
between the inside of the sac .(serosal side) and outside (mucosa! side) when
incubation is aerobic. This does not occur anaerobically. (Reprinted with
permission from The Scientific Basis of Medicine Annual R eviews. London: The
Athlone Press, 1963, p. 172.)
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TABLE 1
Rates of Transference of Amino -Acids an{Concentration Gradients Developed
by Sacs of Everted Intestine
Rate of transference
(µl. / mg dry wt. / hr)

Amino Acid
Praline*
Threonine
Alanine
Glycine*
Serine
Valine
Histidine*
Hydroxyproline
Phenylalanine
lsoleucine

14.0
12.0
11.5
10.1
8. 8
8.2
5.3
6.3
5.4
4.0

±
±
±
±
±
±
±
±
±
±

Concentration gradient
developed

3.2
2.7
3.5
2.4
2.2
2.7
2.8
1.8
2.2
1.2

2.08
1.90
1.82
1.65
1.61
1.42
l.42
1. 36
l.24
1.19

±
±
±
±
±
±
±
±
±
±

0.18
0.28
0.32
0.19
0.19
0.19
0.22
0.14
0.11
0.09

* These results are taken from Wiseman (1955) and are included in this table
for the sake of completeness. The experiments were performed under identical
conditions.
Adapted with permission from J. Physiol. 133: 628, 1956.
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Fig. 3- Typical everted loop experiments using "H-labelled L-tryptophan initially
on the _outside of the sac (mucosa! side) only. Aerobically active transport
r:sult~ m the development of a concentration gradient. Anaerobically only
d1ffus1on occurs. (Reprinted with permission from The Scientific Basis of Medicine Annual Reviews. London: The Athlone Press, 1963, p. 173.)

niques must be developed. Aside
from the difficulty of obtaining
pieces of human gut to make
everted gut sacs, such sacs could
not be used in the same way as
sacs from hamster gut. Besides possible species differences in transport, from the practical standpoint
there is the fact that, in the larger
species, such as dog, the muscle
wall is so thick that penetration of
substance from mucosa through to
the serosal side is ineffective. In humans two major kinds of approaches
have been used. One method is to
take pieces of gut at operations, or
by biopsy, and perform in vitro
studies. I shall discuss these studies
later, mainly in regard to certain
disease states. Another method is
to perfuse the gut under more or
less physiologic conditions. Perfusion experiments . to study intestinal absorption of amino acids
and other substances in the human
have been widely used. In general
the method is as follows: A subject is intubated with a tube which
most often contains two holes, a
perfusing hole and an aspirating
hole, some distance down the gut.
The test substance is then perfused along with a non-absorbable
reference marker, polyethylene
glycol being one that is commonly
and popularly used today. The disappearance from the gut lumen of
the substance to be studied in relation to · changes in marker concentration as a measure of water
absorption has been used as a test
for absorption of the specific substance being studied. Thus, if the
concentration of amino acids drops
during the test, in relation to the
concentration polyethylene glycol,
some of the amino acid has been
absorbed during the period of perfusion.
Table 2 shows the kind of data
obtained when the absorption of
glycine was studied by the perfusion method. As the glycine concentration in the perfusion fluid was
increased, the amount absorbed, ex23
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pressed as millimoles per 15-centimeter gut segment perfused, also
increased. The increase in the
amount absorbed, however, was
not linearly related to the increase
in the glycine concentration of the
perfusion fluid. The rate of glycine
absorption reached a limiting
value. This is illustrated in Figure
6, which shows the results of
studies of L-isoleucine absorption
in two subjects. Plotted are millimoles absorbed against the concentration of isoleucine perfused.
As the concentration increased, the
amount absorbed also increased,
but the absorption rate tailed off as
the concentration increased. If
simple diffusion were the process
involved, one would expect a
straight-line relationship between
the concentration perfused and the
amount absorbed. Instead, this
curve suggests saturation kinetics
and is, thus, consistent with the
idea that some sort of active transport process is taking place.
Figure 7 shows the results of
transport fluids in which the gut
was perfused with solution containing both glycine and L-alanine.
At the bottom of Figure 7 are indicated the concentrations of each
substance for any one study. For
example, "fifty" means that a 50
mM solution of glycine and a 50
mM solution of L-alanine were perfused together. Three patients were
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Fig. 4-Everted loop experiments using 0 H-labelled pyridoxine HCI. The
interrupted line indicates the initial concentrations. With equal concentrations
on both sides of the sac initially (upper figure), there is no active transport for
no concentration gradient develops. When pyridoxine is only present on the
outside (lower figure), it diffuses across into the serosal fluid equally well
whether incubation is aerobic or anaerobic. (Reprinted with permission from
The Scientific Basis of Medicine Annual Reviews. London: The Athlone Press,
1963, p. 174.)

TABLE 2
Absorption of Glycine
Perfused (mM)

10

25
50

75
100
150
300

Absorbed
(mmoles / 15
min / 15-cm
gut segment)
1
3
3
6
7
10
15

± 0
± 1
± 1
± 1
± 1
± 3
± 4

Adapted with permission from
J. Clin. Inv. 45: 1435, 1966.

24

Fig. 5-Hypothetical interaction of neutral amino acid with the membrane
carrier. (Reprinted with permission from T. H. Wilson, Intestinal Absorption.
Philadelphia: W. B. Saunders, 1962, p. 123.)
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studied, and on each several experiments were performed. It can
be seen that, at every concentration
studied, the absorption of alanine,
shown by clear bars, was always
greater than the absorption of glycine. If passive diffusion process
alone were involved, the two substances would not be expected to
so drastically influence each other's absorption.
Another way of testing whether
or not substances share a common
site for absorption involves holding the concentration of one substance constant but changing the
concentration of the other substance. The first is then called the
inhibitor; the second , the test substance. Figure 8 shows a Lineweaver-Burk plot, a double reciprocal plot in which l / S is the
reciprocal of the concentration perfused, and 1/V represents the reciprocal of the amount absorbed .
The solid line connecting these
open circles indicates the absorption of glycine at various concentrations when perfused alone. The
dotted line indicates the absorption
of glycine in the same subject when
perfused at various concentrations
together with 150 mM L-alanine as
the inhibitor. This line is displaced
upwards and to the left; in other
words, the absorption of glycine
is decreased in the presence of
the inhibitor, L-alanine. However,
as the concentration of glycine is
increased, the line tends to meet
the line representing absorption of
glycine alone; it intercepts the vertical axis at the same place. The
fact that the lines under these two
conditions arrive at the same point
is consistent with a form of inhibition called competitive inhibition, that is, where two substances
compete for the same transport
mechanism or for the same binding site. If the inhibition were not
competitive, that is, if the binding
site were being poisoned in some
way by the inhibitor, then the intercepts would not be expected to
be at the same place. These studies
in humans with glycine and alanine

50

40

Cl.-

(f)

I

..0
<(

30

I

--

-------------0
----... ---

I

I

I
I

Q)

I
I

0

~

I

20

I

E

I

I

/o

I

10

I
I
I
I

o:

40

20

60

80

100

120

mM
Fig. 6-Plots of L-isoleucine absorption (mmole/ 15 min/ 15-cm gut segment)
against concentration of isoleucine perfused. The results obtained on two human
subjects with intubation tubes for perfusion are shown.

D
w

z
z

<C

_J

<C

.!.i

15

c:

Q)

E

o>
Q)

"'

-so>

10

a:: E
0

(..)

LO

ml

w

z
0

~

<.!)

LL..

.....

"'

~
:::>
c:

·e

"'

0

~

z

E
E

0
I-

5

~

.....
0

ll..

a::
0

({)

m
<C

0
50

75

150

150

CONCENTRATIONS
IN

THE

OF

GLYCINE

90

AND

·150

300

L-ALANINE

PERFUSATES (mM)

Fig. 7- Absorption of glycine and L-alanine when perfused together at
equimolar concentrations. The first three studies (starting at the left) were
performed in Subject 1, the fourth in Subject 2, and the last three in Subject 3.
In the first study, perfusate osmolality was 245 mOsm per kg and in the last
two studies, 396 and 620 mOsm per kg, respectively. The height of the column
indicates mean absorption. (Reprinted with permission from J. Clin. Inv .
45: 1436, 1966.)
25

AMINO-ACID ABSORPTION

are, thus, consistent with the
studies in everted gut sacs in in
vitro preparations. They indicate
that these particular amino acids
are absorbed by active transport
mechanisms.
The influence of the lipophilic
side chain, suggested by the everted
gut sac experiments, can also be
seen when three amino acids are
tested together. Figure 9 shows the
results of perfusing together at
equimolar concentrations: isoleucine, alanine, and glycine. Isoleucine was always absorbed faster
than alanine, which, in turn, was
always absorbed faster than the
glycine.
On the basis of these studies
and the everted gut sac studies, one
would then predict that L-isoleucine
would be a very effective inhibitor
of glycine absorption. Surprisingly,
however, this was not found. Figure
10 shows Lineweaver-Burk plots of
glycine absorption. The solid line
indicates glycine absorption when
glycine alone was perfused. The
small-dash line indicates the effect
of 150 mM alanine; the large-dash
line is the effect of isoleucine as an
inhibitor at 150 mM. No inhibitory
effect by the L-isoleucine on glycine absorption was seen. Isoleucine, as indicated previously, certainly is transported more quickly
than is glycine. These studies show
that isoleucine is not, however, as
effective an inhibitor of glycine absorption as is alanine. This might
well indicate that there are two
steps in amino acid transport. One
would be a postulated entry step
in which the length of the lipophilic chain is important and in
which the longer side chain of
isoleucine produces greater affinity
with the lipid membrane, enabling
it to be transported more quickly.
The second step, perhaps an exit
step, may be the specific carrier
mechanism and, indeed, may be
the rate-limiting step for the process. Isoleucine and glycine do not
appear to share this later step.
26
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In Vitro Studies on Gut Mucosa
In vitro studies on the distribution ratios of amino acids between
gut mucosa and bathing solution
may shed additional light on specific transport mechanisms for certain amino acids. Results obtained
from such studies are shown in
Table 3. By distribution ratio is
meant the concentration of amino
acid taken up by the mucosa in
relation to the concentration in
the bathing fluid. A distribution
ratio > 1.00 indicates that tissue
accumulated amino acids. For instance, when lysine alone was incubated with the tissue, the distribution ratio was 4.57 ± 1.84. When
lysine was incubated together with
either arginine or cystine, the distribution ratios found were considerably and statistically decreased as
compared to the situation when lysine alone was incubated. Glycine
incubated together with lysine had
no effect on lysine uptake by the
tissue, indicating that lysine, arginine, and cystine very likely form
one family, glycine not being part
of that family. Cystine incubated
alone gives a distribution ratio of
3.6 1 ± 0.85. When incubated together with lysine as the inhibitor,
the distribution ratio is less. Glycine
again has no effect on cystine distribution in the tissue.
Thus, many interesting results
have already been obtained from
in vitro studies and studies on
normal humans in regard to amino
acid absorption of the gut. Much
remains to be learned about the
normal processes by which amino
acids are handled by the gut. The
fact that various mixtures of amino
acids may be handled differently
can be of considerable metabolic
significance, since it has been
shown that lack of certain amino
acids in the diet results in poor
growth rates and poor wound healing rates. It appears that the body
has to be presented with certain
optimum mixtures of amino acids
for optimum function . With this,
then, as some indication of what
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TABLE 3
Inhibition of Normal Gut Mucosa! Uptake of L-Lysine-C 14 and L-Cystine-S 3'
by a Second Amino Acid
Distribution
Ratio

Significance of difference from control (p)

±
±
±
±

< 0.001
< 0.001
> 0.6

Substrate

Inhibitor

No. of Tests

L-lysine
L-lysine
L-lysine
L-lysine

None
L-arginine
L-cystine
Glycine

12
4
4
3

4.57
1.13
1.77
4.81

L-cystine
L-cystine
L-cystine

None
L-lysine
Glycine

10

3.61 ± 0.85
2.31 ± 0.35
3.63 ± 0.96

4
3

1.84
0.22
0.26
0.40

< 0.01
> 0.9

Adapted with permission from Science 143: 483, 1964.
Copyright by the American Association for the Advancement of Science.
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TABLE 4
Uptake of L-Lysine-cu and L-Cystine-S 36 by Gut Mucosa from Normal Subjects
and Patients with Cystinuria
Distribution Ratio (Mean ± SD)
L-lysine
Normal subjects
Cystinuric subjects

1.4 ± 0.26

L-cystine
4.5 ± 1.26
1.2 ± 0.28

(p < 0.001)

(p < 0.001)

13.4 ± 1.91

Adapted with permission from Science 143: 483, 1964.
Copyright by the American Association for the Advancement of Science.

TABLE 5
Evidence Favoring a Jejuna! Transport Defect for Tryptophan in Hartnup
Disease
Ingested L-tryptophan can be recovered in feces of patients but not of
normal subjects.
2. Plasma levels of tryptophan after ingestion of the amino acid rise more
slowly and remain high for a longer time in cases of Hartnup disease than
in normal subjects.
3. Bacterial breakdown products of tryptophan are excreted in greater amounts
and for longer periods after ingestion of the amino acid in Hartnup disease
patients than in normal subjects.
1.

Adapted with permission from Quart. J. Med. 29: 415, 1960.

TABLE 6
Evidence Concerning a Defect of Tryptophan Absorption in the Blue Diaper
Syndrome
1. Tryptophan content of stools, before and after loading with tryptophan,

higher in patients than controls.
2. Excess urinary excretion of indolic metabolites, especially after tryptophan
feeding, formed in lower gut by action of bacteria on unabsorbed tryptophan.
3. I. V. tryptophan in patient increased metabolites of kynurenine pathway
several times as compared to similar amounts of oral tryptophan. No such
discrepancy between oral and I. V. doses found in controls.
4. Plasma tryptophan levels following oral loading low in patients compared
with controls.
Compiled with permission from Quart. J . Med. 29 : 407-421, 1960.
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the state of the art is at the
moment insofar as amino acid under normal conditions is concerned, let us turn briefly to some
abnormalities of amino acid absorption.

Abno rmalities of Amino Acid
Absorption

Cystinuria
The first entity to be discussed
is cystinuria. This is a genetically
determined disorder in which the
outstanding clinical manifestation
is the formation of cystine renal
calculi. It has been known that
aminoaciduria occurs in cystinuric
patients. Only over the last few
years, however, has it been determined that a specific amino acid
transport defect can also be seen
in the gut. The results of in vitro
studies with isotopically labeled
lysine and cystine incubated with
gut mucosa obtained from cystinuric and normal subjects are shown
in Table 4. The amino acid distribution ratios in the gut of normal
subjects were considerably and statistically significantly higher than
the distribution ratios seen when the
gut mucosa of cystinuric subjects
was used. Thus, cystinuric gut mucosa has a specific defect for concentrating these particular amino
acids. The defect in cystinuria is
confined to the basic amino acids,
since other amino acids that have
been studied do not show the transport difficulties.
Another way of studying the
amino acid absorption defect in
cystinuria is to follow the fate of
ingested ornithine and lysine. When
this was done, amino acid was
found in the stool, and various
breakdown products of the amino
acids were found in both the feces
and the urine. In normal subjects,
feeding of these amino acids was
not
accompanied
by
similar
changes. These findings indicate
that, in cystinuria, the amino acids
are inefficiently absorbed by the
small bowel and, thus, can be acted
on by colonic bacteria. Thus, both

B. FLESHLER

by in vitro experiments with gut
mucosa! biopsies and by feeding
of amino acids, it can be demonstrated that there is a defect in
handling of basic amino acids by
patients with cystinuria.

'1000
Hartnup Disease

Another disorder in which a defect in amino acid absorption can
be demonstrated is a rare genetic
disorder named Hartnup disease.
This disorder is characterized by
a pellagra-like skin rash, a severe
but reversible cerebellar ataxia,
various psychiatric manifestations,
and an aminoaciduria involving alanine, serine, threonine, and a
number of other amino acids. Glycine, aspartic acid, glutamic acid,
lysine, arginine, and ornithine are
excreted in normal amounts in
Hartnup disease. Some observations
concerning gut absorption abnormality in Hartnup disease are summarized in Table 5. Ingested tryptophan can be recovered in the
feces of patients but not of normal
subjects. After ingestion of the
amino acid, plasma levels of tryptophan rise more slowly and remain
high for a longer time in cases of
Hartnup disease than in normal
subjects. Furthermore, after ingestion of the amino acid, bacterial
breakdown products of tryptophan
are excreted in greater amounts and
for a longer period in Hartnup
disease patients than in normal
subjects. These findings could be
explained by an enzymatic block
along the metabolic sequence from
tryptophan to nicotinic acid or by
an abnormal intestinal environment
supporting a peculiar gut flora
which deranged the metabolism of
the host. The most likely explanation, however, is that the kidney
and the gut share a metabolic abnormality for the transport of
amino acids. Certainly furhetr
studies need to be done before this
hypothesis can be accepted.
Except for the deficiency of
nicotinic acid and the production
of the pellagra-like rash in Hartnup disease, the effect of amino
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acid absorption deficiency in both
Hartnup disease and cystinuria is
not presently clear on a clinical
basis. It has been suggested that
growth may be retarded in these
patients, and calculations of the
amount of amino acid lost in the
urine and potentially unabsorbed
indicate that the amino acid intake
may be marginal. This may be
particularly true for lysine, which
is a limiting amino acid in many
nutritional studies.
Blue Diaper Syndrome

Another disorder in which there
also appears to be a defect in
tryptophan absorption is the socalled Blue Diaper Syndrome, a
familial disease in which hypercalcemia and nephrocalcinosis are associated with a defect in the intestinal transport of tryptophan
(Table 6). Bacterial degradation of

the tryptophan leads to excessive
indole production and, thus, to indicanuria, which, on oxidation to
indigo blue, causes peculiar bluish
discoloration of the diaper; hence,
the picturesque name.
Phenylketonuria
In phenylketonuria there also
may be a defect in absorption of
amino acids, at least as tested by
oral administration of arginine.
Figure 11 shows the appearance of
arginine in blood after feeding
labelled arginine to a patient with
phenylketonuria. The appearance
of the label in the serum was very
much delayed, and the radioactivity levels achieved were very much
lower than in a normal control subject. This is, at best, only preliminary suggestive evidence for malabsorption, since appearance curves
by themselves are subject to many
-29
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variables and cannot be taken entirely as indicating an amino acid
transport defect. That this defect
may, however, be a reversible phenomenon is demonstrated in Figure
12, where line A is the appearance
of radioactivity in the blood after
feeding of radioactive Ieucine in
a patient with phenylketonuria.
Line B shows the results of the
same test in the same subject after
a period of phenylalanine deprivation. Considerable improvement in
amino acid uptake is seen, matching the observation on the normal
control subject of the same age.
These data and other that have
been gathered in terms of the effect of phenylalanine on amino acid
transport into brain tissue suggest
that the abnormality leads to a
metabolic block of amino acid
transport which may be reversible
in nature.
Efject of Galactose on
Acid Transport

Amino

As a final example of a disorder in which amino acid transport by the gut may be affected,
the effect of galactose has been
studied. Table 7 shows that the
gut mucosa of rats, prefed 30%
galactose for several months, had
a diminished uptake of various
amino acids compared to control
values. Prefeeding rats with a
variety of other sugars such as
glucose, xylose, and ribose has no
effect, whereas prefeeding with
fructose has a minimal effect. The
possible implications for the human
disease, galactacemia, are evident.
Co nc lusio n
In concluding, it is of some
use to compare the criteria for
active and passive transport presented in Table 8. Although somewhat more sophisticated subdivisions of this table can be made,
I think it is useful to review the
data in this way. In active transport, the substance is transported
from a fluid of a lower concentration to that of a higher; passive
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TABLE 7
Amino-Acid Transport by Jejuna! Slices from Rats Fed 30 Per Cent
D-Galactose for 2-3 Months
Distribution Ratios
Intestinal
Slices
Control
Galactose-fed
p

L-alanine

L-valine

Glycine

L-lysine

4.0 ± 0.6 4.2 ± 0.9 2. 3 ± 0.5 J.6 ± 0.4
2.8 ± 0.8 2.3 ± 0.3 l.5 ± 0.7 1.3 ± 0. 3
< 0.05
< 0.01
< 0.05
< 0.01

Hydroxy-Lpro line
1.9 ± 0.3
1.3 ± 0.5
< 0.05

Adapted with permission from Nature 205: 700, 1965.

diffusion movement is only from a
higher concentration to a lower.
The rate of transport is not necessarily related to molecular volume,
whereas in passive diffusion, by and
large, smaller molecules diffuse at
a greater rate. In active transport
there is stereospecificity, that is,
stereoisomers are generally transported less efficiently than the
naturally occurring compounds. It
suggests that there is a specific kind
of receptor site to which the transported molecule must be attached.
In active transport the rate of

transport is not proportional to the
concentration gradient. It shows
the saturation phenomenon at high
substrate concentrations. This
does not occur in passive diffusion .
In active transport one can show
competitive inhibition by related
compounds; the rate of transfer
is unaffected by the presence of
closely related compounds in passive diffusion. Transport rate is
reduced by metabolic poisons when
material is actively transported,
whereas the rate of transfer is not
greatly affected in passive diffusion

B. FLESHLER
RIDGE. The metabolic disorder in
Hartnup disease. Quart. J. Med.
29: 407-421, 1960.

TABLE 8
Comparison of Active Transport and Passive Diffusion
Active Transport
Relation to concentration Transport from fluids of a
gradient
lower to a higher concentration occurs
Relationship to apparent Speed of transport not
molecular volume in
necessarily related to apcompounds of similar
parent molecular volume
type
Stereospecificity
Stereospecific. Stereoisomers in general are transported less readily than
naturally occurring compounds
Rate of transfer not proSaturation of system at
high concentrations
portional to concentration
gradient. and approaches
a limiting maximal value
Competitive inhibition by Rate of transfer reduced
related compounds
by simultaneous transport
of a related compound
sharing the same transport system
Non-competitive
Transport reduced by
inhibition
metabolic poisons--e.g.
dinitrophenol

Passive Diffusion
Movement only from fluids
of a higher to a lower concentration
Smaller molecules in general diffuse at a greater rate

Rate of transfer of stereoisomers identical

Rate of transfer proportional to concentration
gradient and no limiting
maximal rate occurs
Rate of transfer unaffected
by the presence of closely
related compounds

SAUNDERS, S. J. AND K. J. ISSELBACHER.
Inhibition of intestinal amino-acid
transport by sugars. Nature 205:
700-701, 1965.
THIER, s., M. Fox, s. SEGAL, AND
L. E. ROSENBERG. Cystinuria: in
vitro demonstration of an intestinal
transport defect. Science 143: 482484, 1964.
WILSON, T. H . Intestinal Absorption.
Philadelphia: W. B. Saunders, 1962,
pp. 33, 123.
WISEMAN, G. Active transport of
amino acids by sacs of everted
small intestine of the golden
hamster (Mesocricetus auratas) . J.
Physiol. 133: 626- 630, 1956.

Rate of transfer not
affected unless obvious
cellular damage occurs

Reprinted with permission from Brit. Med. J. 1: 328, 1964.

unless cellular damage has occurred.
Thus, there are many characteristics by which one can attempt to
assess whether or not materials are
transported passively or require a
specific energy-dependent system
for their movement. There is reason to believe on the b asis of the
evidence presented here, on the
basis of in vitro studies with
everted gut sacs a nd other tissue
preparations, on the basis of physiologic perfusion studies, and, perhaps most significantly, on the
basis of studies in various disease
states with specific amino acid
transport defects, that amino acid
transport by the gut is an active
process which may be affected by a
variety of inhibitors in pathophysiologic states. We are just beginning
to understand the importance of
these defects in human metabolism.
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Pathogenesis of Hepatic Encephalopathy*
Z. RENO VLAHCEVIC

Veterans Administration Hospital, Richmond, Virginia 23219

Severe parenchymatous diseases
of the liver, both acute and chronic,
are frequently associated with hepatic encephalopathy. This term is
preferable to that of hepatic coma,
as it encompasses the whole spectrum of changes from bizarre alterations of behavior to various
degrees of disturbance of consciousness, as well as protean neurologic
manifestations. In many instances
it is a reversible phenomenon, occurring either spontaneously or as
the result of various therapeutic
agents. The puzzling feature of
hepatic encephalopathy is the discrepancy between dramatic clinical
features and paucity of histopathological changes in the brain. The
only histological changes encountered with regularity in patients
with this entity are diffusely swollen and enlarged astrocytes (Adams and Foley, 1953). With no macroscopic or microscopic changes to
account for cerebral dysfunction,
it is likely that hepatic encephalopathy is caused by profound, yet
undefined metabolic abnormalities.
A relationship between ammonia
toxicity and cerebral dysfunction
has been suspected since the discovery of "meat intoxication" in
Eck fistula dogs. The clinical relationship between liver disease, cerebral dysfunction and disordered
ammonia metabolism was established by Gabuzda, Phillips, and
Davidson (1952) and confirmed
by others.

* Presented at the Thirty-Ninth
Annual McGuire Lecture Series, November 9-10, 1967, Medical College
of Virginia, Richmond.

Sources of Ammonia

The major sources of ammonia
in humans are the bowel and the
kidney. Ammonia is produced in
the bowel by the action of bacterial and digestive enzymes on
protein and urea, the major contributor probably being the right
colon ( Gryska and Barsamian,
1958; Silen et al., 1955; Webster,
Davidson, and Gabuzda, 1958). In
patients with cirrhosis, the upper
small bowel, normally sterile, is
contaminated by bacteria, thus
contributing significantly to ammonia production (Martini et al.,
1957). The reason for abnormal
bacterial growth in the upper small
bowel in patients with cirrhosis is
not known.
Hydrolysis of the urea is an additional source of ammonia. About
25 % of the endogenous urea is
not excreted by the kidney but is
hydrolyzed in the gastrointestinal
tract at a constant rate of 0.3 mg
per hour to a total of 7.2 gm of
urea daily. This is equivalent in
nitrogen content to 11 gm of
NH 4 Cl or 18 gm of protein (Walser and Bodenlos, 1959). As patients with advanced cirrhosis in
terminal stages frequently develop
azotemia secondary to renal failure, it is easy to visualize how
hydrolysis of this excess urea in
the gut could precipitate hepatic
coma. All these factors, when coupled with a larger protein load,
either secondary to bleeding or
high protein diet, can contribute
significantly to the occurrence of
hepatic encephalopathy.
The second major source of ammonia is the kidney. Ammonia is
produced in the kidney by deamiMCV QUARTERLY 4(1): 32-37, 1968
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nation of glutamine and other
amino acids, resulting in higher
renal vein ammonia. The difference between renal vein and arterial ammonia is even more pronounced in patients with cirrhosis,
particularly if they are potassium
deficient, on diuretic therapy, or
both (Weil-Malherbe, 1950; Owen
et al., 1960). The mechanism for
preferential secretion of ammonia
into the renal vein is not known.
With acetazolamide therapy, increase in renal vein ammonia was
coupled with equivalent fall in
urinary ammonia and a rise in
urine pH. The latter may explain
the shift in partition of ammonia
between urine and renal vein.
The role of hypokalemia in an
increased renal production of ammonia is not understood, but it
can be prevented by correction of
potassium deficit. In patients with
liver disease who are frequently
rendered hypokalemic with injudicious use of diuretics, this mechanism may be responsible for the
precipitation of hepatic encephalopathy.
Removal Mechanisms and
Distribution of Ammonia

Ammonia is detoxified in the
liver by forming urea through the
Krebs-Henseleit cycle. As a result
of the marked collateral circulation and hepatocellular disease,
the removal of am monia by the
liver in patients with cirrhosis is
diminished. Very rarely in cases
of massive fulminating liver failure, the urea cycle does not function at all, resulting in decreased
blood urea nitrogen levels.
The removal of ammonia from
the blood and tissues can also be
accomplished through the reaction
in which a-ketoglutarate combines
with ammonia to form glutamic
acid (Weil-Malherbe, 1950).
Through the process of transamination, .a-ketoglutarate can again become available either to combine
with more ammonia or to continue
in the tricarboxylic acid cycle (Fig.
1). Furthermore, glutarnic acid

can react with ammonia to form
glutamine in the reaction requiring ATP.
These reactions, thus, probably
serve as a defense against accumulation of ammonia, and at the
same time offer a reasonable explanation for frequent elevation
of glutamic acid and glutamine in
patients with chronic liver disease.
Exhalation of ammonia via the
lungs is a minor mechanism of
ammonia removal.
As a consequence of hepatic
parenchymal disease and portalsystemic shunts, the nitrogenous
compounds from the portal blood
bypass the liver and reach systemic circulation, resulting in the
elevation of blood ammonia. Blood
ammonia, however, is not a good
index of "ammonia toxicity" for
several reasons. First, blood ammonia correlates poorly with the
state of consciousness (Moore,
Strohmeyer, and Chalmers, 1963).
Secondly, in the congenital defects
of urea biosynthesis, blood ammonia levels may be much higher
than those found in patients with
hepatic coma with no neuropsychiatric manifestations (Russell et
al., 1962) . Finally, the experiments by Warren et al. ( 1960;
Warren, 1958; Stabenau, Warren
and Rall, 1959) have shown that
another variable, pH, might play
an important role in the pathogenesis of hepatic coma. They observed that the differential toxicity
of various ammonium salts de-
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pended upon the change in the pH
of the blood induced by a given
salt.
Ammonia, in the blood or any
biological fluid, exists in two forms :
ammonium ion (NH4 +) and free
ammonia (NH3°) . According to
the Henderson-Hasselbalch equationNH3°
pH = pK" +log NH. +
the relative proportion of each
component is directly dependent
upon pH. Knowing the pK,. of
ammonia (about 9 .15) , total blood
ammonia (obtained by any standard microdiffusion test) and pH,
one can calculate the relative proportion of ionized (NH4 +) and
un-ionized free ammonia (NH 3°) .
The relative proportions of un-ionized ammonia at pH's of 6, 7, 8,
and 9.15 are approximately 0.1 %,
1 %, 10 % , and 50 % . According to
present concepts, only un-ionized
free ammonia is capable of crossing
the cell membrane. At the normal
blood pH only a small proportion
of ammonia is in this form. The
change of pH to the alkaline side
will increase the proportion of unionized ammonia (NH3 ) and, thus,
theoretically, increase the chance of
inducing hepatic encephalopathy.
According to the pH gradient
distribution hypothesis, distribution
of ammonia from blood to tissue
seems to be dependent upon a pH
difference between the two compartments. If a membrane, such as

KETOGLUTARIC A C I D x N H 3 + DPNH + H +
DEHYDROGENASE
L - GLUTAMIC ACID

H20 + DPN +

L _ ASPARTIC ACID x c L - KETOGLUTARJC A C I D x NH3 + DPNH + H +
TRANSAMINASE
OXALOACETIC ACID

DE HYDRO GE NASE
L - GLUTAMIC ACID

H20 +

DPN ~+

Fig. I-Ammonia detoxication reaction involving a-ketoglutaric Acid. The
transamination reactions involving glutamic acid are also presented.
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the blood-cerebrospinal fluid barrier, is permeable only to un-ionized
ammonia, the concentration gradient which normally exists between
·extra- and intracellular fluid should
be maintained, depending upon the
pH in each compartment. With the
change of this gradient, the redistribution of un-ionized ammonia
·occurs, providing the change takes
place on one side of the membrane
·only or both sides in the opposite
direction. Consequently, an in·crease in extracellular pH, such as
in metabolic alkalosis, will both
increase the relative proportion of
un-ionized ammonia and facilitate
its transfer across the membrane,
resulting in a rise of intracellular
:ammonia.
Respiratory and metabolic alkalosis are frequently encountered in
patients with cirrhosis. Respiratory
alkalosis with hyperventilation is
the most frequent acid-base disturbance in these patients. The
underlying mechanism for its oc·Currence is not clear. This type of
alkalosis, however, does not cause
·significant change in the pH gra·dient, as carbon dioxide diffuses
freely across the cell membranes
and, consequently, no change in
a mmonia distribution occurs. Conversely, in patients with metabolic
.alkalosis, the pH gradient will be
increased, as the pH change will
·Occur on one side of the membrane
·only, thus resulting in redistribu-

tion of ammonia. Hypokalemic,
hypochloremic alkalosis accompanied by intracellular acidosis
frequently occurs in patients with
cirrhosis who are treated with potent diuretics. As a result of metabolic alkalosis, formation of un-ionized ammonia (NH3°) is favored,
and its transport across the membrane is facilitated. This mechanism may be partially responsible
for the frequent precipitation of
hepatic encephalopathy in cirrhotics on this therapy.
Whether aforementioned theoretical considerations play an important role in the pathogenesis of
hepatic coma is not as yet entirely
clear, largely because no direct
method for measuring un-ionized
ammonia (NH3 °) is available.
Clinical trial with the intention
of implementing these theoretical
considerations in patients with hepatic coma was not successful
(Warren et al., 1960) . The administration of O.lN HCL intravenously for a brief period of time,
in an attempt to lower the pH, did
not lead to any improvement in
the state of consciousness. The
duration of this clinical trial was
very short and, therefore, inadequate to fully test this hypothesis.
Pathogenetic Mechanisms

Hepatic encephalopathy can be
classified either as spontaneous

TABLE 1
Precipitating Factors
Gastrointestinal Bleeding
Excessive Amounts of Nitrogenous Substances (Dietary Protein, Ammonium
Salts, Urea, Amino Acids)
Azotemia
Diuretics
Metabolic Alkalosis With or Without Hypokalemia
Acute Infections
Sedatives, Hypnotics, Analgesics (Chloral Hydrate, Paraldehyde, Barbiturates,
Opiates)
Major Surgical Procedures
Massive Paracentesis
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(endogenous) or induced (exogenous). As far as the pathogenesis is concerned, this classification is somewhat arbitrary. It
only implies that exogenous coma
is precipitated by a variety of factors (Table 1) and, consequently,
does not necessarily imply extremely poor liver function. Conversely, spontaneous or endogenous coma usually implies active,
sometimes fulminating liver disease, occurring without presence
of precipitating factors and, consequently, carries a worse prognosis.
The pathogenetic mechanisms
involved in hepatic encephalopathy
are not known. It is generally accepted, but not proven, that either
ammonia or a nitrogenous substance liberating ammonia is in
some way associated with the syndrome of hepatic encephalopathy.
In addition to, or because of disordered ammonia metaholism, patients with hepatic encephalopathy
have a markedly altered metabolism of glucose and oxygen. This
is manifested by the accumulation
of various intermediates of tricarboxylic acid (TCA) cycle, pyruvic
and lactic acid in the blood and
in the spinal fluid. Furthermore,
brain oxygen uptake and cerebral
blood flow in these patients are decreased between 25 % and 50%.
All of these facts indicate that
profound metabolic biochemical
changes take place in these patients,
some of them affecting cerebral
energy metabolism. Such disturbance of cerebral energy metabolism
is now thought to be the basis of
neurological changes in ammonia
intoxication. Neurologic findings of
hepatic encephalopathy such as
asterixis, decerebrate rigidity, hyperpnea and coma suggest malfunction of the specific structures in the
base of the brain and possibly their
cortical connections (Magoun ,
1963; Plum and Posner, 1966).
The understanding of biochemical disorders involved in hepatic
coma was hampered by the impossibility of studying coma in humans. Most of the available data
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an important intermediate of the
TCA cycle. They suggested that,
when an excess of ammonia is presented to the brain, depletion of
a-ketoglutarate takes place through
its reaction with ammonia to form
glutamic acid. This reaction (Fig.
2) is catalyzed by glutamic dehydrogenase and uses DPNH, as an
electron donor. Diversion of aketoglutarate from the TCA cycle
diminishes the rate of formation of

are from in vitro experiments or
animal models. Thus, it must be
stressed with great emphasis that
extrapolation of these experiments
to human situations should be done
with reservation and due caution.
Hessman and Hessman (1955)
proposed a hypothesis which attempted to link the effect of excess
ammonia in the brain with the effectiveness of the TCA cycle. The
common link is a-ketoglutarate,
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Fig. 2-Metabolic interrelationship between ammonia metabolism and TCA
cycle in the brain. The dotted (. . . . . ) line illustrates metabolic derangements
of the TCA cycle postulated to occur as a result of excess ammonia. (Adapted
with permission from Gastroenterology 49: 699, 1965.)

the succeeding members of the
cycle. It is apparent that this will
interfere with oxygen utilization
and reconstitution (or formation)
of adenosine triphosphate (ATP),
an overall process known as oxidative phosphorylation. The formation of ATP will be diminished in
direct proportion to the depletion
of a-ketoglutarate.
The second line of defense in
the process of ammonia detoxication in the brain is offered by the
reaction in which glutamic acid
reacts with ammonia to form glutamine (Fig. 2). This reaction requires ATP for energy and is catalyzed by glutamine synthetase. As
a result of the accentuated formation of glutamine, this compound
is elevated in the cerebrospinal
fluid and blood in patients with
hepatic coma.
Worcel and Erecinska (1962)
have also shown that the addition
of ammonia to rat liver mitochondria inhibited oxygen uptake when
a-ketoglutarate and pyruvic acid
were used as substrates. They postulated that the inhibitory action
of ammonia on the respiration of
rat liver mitochondria is due to
competition for DPNH between
glutamic dehydrogenase and electron chain transport (Fig. 2).
If these theoretical considerations are correct, when an increased amount of ammonia crosses
the blood-brain barrier and reacts
with a-ketoglutarate and glutamic
acid, brain ATP levels should be
decreased as a result of the combination of inadequate formation
and excessive utilization. For the
same reasons, a-ketoglutarate would
be expected to be low. Schenker
et al. ( 1967; Shorey, McCandless,
and Schenker, 1967) measured
ATP and a-ketoglutarate in the
brain of rats who were given toxic
doses of ammonium acetate .. ATP
and a-ketoglutarate were measured
in the rapidly frozen base and cortex of the brain. Their results indicate that the ATP levels were
unchanged in the cortex but definitely decreased at the base of the
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brain, with ammonia concentration
equal in both parts. These experiments offer for the first time in
vivo evidence of the toxic effect
of ammonia on energy metabolism
in the brain. At the same time, a
measurable decrease of phospho-creatine at the base was observed.
Glucose and glycogen decreased
significantly in both base and cortex.
The mechanism for this selective depletion of ATP at the base
of the brain is not known, but it
-could be due to the impaired formation of ATP, its increased utilization, or the combination of both.
The significance of selective ATP
and phosphocreatine depletion at
the base of the brain is not known.
However, the available evidence
suggests that one-third depletion of
ATP is deleterious in anoxic rats
( Dahl and Balfour, 1964). The
role of ATP in the maintenance
of proper cerebral function is also
not known, though it has been
postulated that energy provided by
ATP may be required for proper
transmission of nerve impulses
{Skou, 1965). The relationship between the state of consciousness
and ATP depletion was not clarified in these experiments.
The determination of a-ketoglutarate did not demonstrate any depletion of this intermediate either
in the cortex or at the base of the
brain. It is possible, however, that
the current methods cannot assess
small cerebral pools in highly differentiated compartments. These results, as well as the failure of ammonia to interfere in vitro with
e ither respiration or phosphorylation, are not compatible with Bessman's hypothesis.
McK.hann and Tower ( 1961)
showed that the addition of ammonium chloride to the brain
cortical slices caused significant reduction of oxygen uptake when
pyruvate or a-ketoglutarate were
used as a substrate. They concluded that ammonium interferes
with oxidative decarboxylation of
pyruvate and a-ketoglutarate. This
36

observation offers another possible
hypothesis applicable to the human
situation. Other factors such as deficient acetyl coenzyme A, metabolic inhibitors-either not detoxified in the liver or produced as a
result of ammonia intoxicationand medium chain fatty acids are
a few possible candidates which
have not yet been adequately studied.
Though a great step forward ,
these experiments have not yet offered a new concept relating to
the pathogenesis of hepatic encephalopathy.
The concentrated efforts to explain hepatic encephalopathy from
the standpoint of disor<lered ammonia metabolism heretofore have not
been rewarding. Geiger (1958),
however, in his experiment with
perfused cat brain, has opened new
avenues and new approaches. He
found that cat brain preparations
remained viable and were ahle to
perform normal neurolo~ical and
biochemical functions for a prolonged period of time with the liver
inserted into the circulation. This
was not the case when the brain
preparation was perfused with the
red cell suspension in the Ringer
solution devoid of organic substances normally present in blood.
This emphasizes the importance of
the metabolic interrelationship between the liver and the brain. The
implication of these experiments is
that normal brain function deoends
upon a normally functioning liver,
which may supply the brain with
some important metabolic precursors such as cytidin and uridin
which the brain is itself incapable
of producing (Webster, 1965). In
patients with cirrhosis, this metabolic interrelationship might be disturbed, resulting in abnormal brain
function.
A repeat of the Gei~er experiments with these thoughts in mind,
as well as new and systematic approaches in other areas, might offer
additional insight into the pathophysiology of this fascinating and
perplexing entity, which is so in-

adequately understood at the present time ..
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The Surgical Management of
Hirschsprung's Disease
LESTER W. MARTIN

The Children's Hospital, Cincinnati, Ohio 45229

Etiology, Early History

Aganglionic megacolon, or
Hirschsprung's disease, is characterized by constipation dating from
birth. The symptoms of constipation or obstruction are due to a
lack of parasympathetic innervation resulting from congenital absence of nerve ganglia of the myenteric and submucosal plexuses
of Auerbach and Meissner. The
aganglionic segment begins at the
anus and extends proximally for
a varying distance. In most cases
of Hirschsprung's disease, the
aganglionic segment involves only
the rectum and the lower sigmoid
colon. Occasionally, the aganglionic
segment may involve most or all
of the colon and, rarely, the lower
small intestine.
The first description of Hirschsprung's disease is usually credited
to a Dutch surgeon, Frederici Ryuschii, who published a detailed report in Latin in the seventeenth
century (Benson et al., 1962; Jayle,
1909). Hirschsprung's Classical Paper was delivered before the Berlin Congress for Children's Diseases
in 1886. He considered the dilated
colon to be the primary cause, although he did mention that the
rectum was not dilated and seemed
slightly narrower than the normal
rectum and that the mucosa of the
colon was ulcerated, inflamed and
edematous (Hirschsprung, 1887).
The true etiology remained generally poorly understood in spite
of correct observations of several
authors dating from 1901, indicating the primary defect. Swenson
and Bill ( 1948) have described a
sphincter-saving curative proctec38

tomy removing the aganglionic segment of the colon. This operation
was a significant milestone in the
treatment of this previously incurable disease. However, it is associated with a high instance of postoperative complications. Several authorities have expressed concern
regarding long-term complications
of proctectomy for this as well as
other diseases (Clausen and Davies,
1963) and have expressed a preference for preservation of the rectum in this histologically benign
condition (Duhamel, 1960; Martin
and Altemeier, 1962). A low anterior abdominal resection has been
preferred by some (State, 1952) .
Others have proposed a rectosigmoid myotomy similar to the Ramstedt procedure and Heller operations (Martin and Burden, 1927) .
Duhamel ( 1960) has described a
procedure which consisted of excluding the rectum, leaving it in
place, and establishing an oblique,
end-to-side anastomosis at the skin
level. This procedure avoided the
complications of proctectomy and,
at the same time, the anastomosis
was low enough to avoid residual
symptoms of Hirschsprung's disease. There were some complications relating to accumulation of
stool in the blind rectal stump.
Also, the sensory urge to defecate,
derived from the tense, filled rectum, was lost, since the rectum was
completely bypassed by the procedure. This operation was further
modified by lengthening the anastomosis as a long, side-to-side attachment of the colon to the rectum (Martin and Altemeier, 1962) .
Soave (1964) has recently described
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an operation which preserves the
muscular wall of the rectum but
removes the mucosa and does a
pull-through procedure, bringing the
ganglion-containing colon through
the muscular sleeve of the rectum,
which is kept in place.
Operative Procedure
The operation which we now employ is a modification of the above
procedures (Martin and Caudill,
1967). The rectum is left in place
but is completely included in the
fecal stream, so that the sensory
function is preserved. Dissection
within the pelvis is minimal, thus
reducing the risk of injury to the
small nerve fibers going to the
bladder and to the ejaculatory
mechanism. The anastomosis can
be performed at a low level without disturbing the internal sphincter.
The operation (Fig. 1) is carried
out with the patient in the lithotomy
position. The abdomen is opened
through a generous, left paramedian
rectus-retracting approach. The rectum is divided just above the peritoneal floor, with the anastomosis
clamps being placed obliquely, preserving a longer segment of rectum
anteriorly. Resection of the aganglionic sigmoid and descending colon
is then carried out proximally to a
level where adequate numbers of
ganglion cells are identified microscopically on frozen section by the
pathologist. Following resection,
the end of the colon is then closed
and inverted with interrupted silk
sutures. The ends of the sutures are
left long so that they may be
grasped with the clamp to be subsequently inserted through the rectum.
The presacral space is next opened and dissection carried downward in the midline posterior to
the rectum, using the finger to facilitate dissection until the level of
the pelvic diaphragm is reached.
The surgeon then proceeds to the
perinea! portion of the operation.
The anus is gently dilated and the
rectum thoroughly irrigated with

sterile saline solution followed by
a mild antiseptic. Employing the
Bovie electrosurgical unit, a transverse incision is made around the
posterior half of the rectal wall at
the apex of the anal crypts. The
wall of the rectum posteriorly is
dissected gently from the levator
muscles, and the presacral space
previously dissected from above is
then entered. A long, curved hemostat is inserted from below into
the presacral space, and the lower
end of the colon is grasped and
drawn through the wound in the
posterior rectum. Several fine catgut sutures are placed about the

circumference of the opening of
the posterior rectal wall, and an
open, end-to-side anastomosis is
created from the end of the colon
to the posterior wall of the rectum.
After the sutures closing the end of
the colon have been removed, a
long spur-crushing clamp of the
Mikulicz variety is inserted, with
one prong in the rectum and one in
the colon, and a clamp inserted the
full length of the rectal stump.
The surgeon then returns to the
abdominal part of the operation,
and an open anastomosis is carried
out betweeen the end of the rectal
stump and the side of the adjacent

Fig. 1- A. Following resection of the aganglionic portion of the colon, the
proximal end is placed in the presacral space and the end of the colon anastomosed to the posterior wall of the rectum 0.5 cm proximal to the mucocutaneous junction through an incision in the posterior wall of the rectum made
transversely through the dilated anus.
B. Anastomosis from the proximal end of the rectum to the side of the adjacent
colon is created, employing the open anastomosis technique.
C. The remaining colo-rectal septum is obliterated by means of a spur-crushing
clamp which is inserted from below by an assistant while the surgeon is completing the proximal anastomosis. This permits placement of the clamp under
direct vision before the anterior row of the anastomosis has been completed.
The clamp is tightened in position and obliterates the remaining colo-rectal
septum within a period of three to five days.
D. The appearance of a completed anastomosis.
E. The interior of the completed anastomosis.
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colon. After the posterior half of
the anastomosis has been completed, the spur-crushing clamp,
which was previously inserted
through the perinea! approach, is
inserted further by the assistant
and placed under direct vision by
the surgeon, so that the clamp includes the entire length of the septum to assure its complete ablation.
The anterior half of the anastomosis is completed in the usual manner. If possible, the peritoneal floor
is repaired above the anastomosis.
A proximal diverting colostomy has
generally been established previously and is considered advisable
in most cases.

Results
This operation has been employed in 17 children with Hirschsprung's disease. Their ages were
from one to four years. All have
been followed up at regular intervals, with the longest follow-up
being four years. One child developed mild pelvic cellulitis, fever
and leukocytosis following discharge from the hospital. The cellulitis cleared promptly with oral
antibiotics. Three children developed mild abdominal distention
and diarrhea, interpreted as enterocolitis, one to thre~ months
following closure of the colostomy.
Their symptoms cleared following
anal dilatation. Mild constipation
in two children has required occasional medication. None have
had problems related to accumulation of stool in the rectum. The degree of bowel control has been
most gratifying. The children have
from one to three bowel movements daily, and their underclothing remains clean during the interim. Clinically, the results of this
operation have been satisfactory.

tain advantages over the original
Duhamel operation and over the
classic Swenson operation. It can
be recommended as a safe operation for Hirschsprung's disease,
and, in our experience, has given
satisfactory results.
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Thirty-seven sampiings of right duct lymph, thoracic
duct lymph, arterial blood, mixed venous blood and
expired air, made separately and simultaneously in 59
out of 300 anesthetized mongrel dogs, showed a mean
value of 61 mm Hg for the right duct lymph PO, and
37 mm Hg in the thoracic duct lymph. The pulmonary
lymph PO, was probably higher than that in the right
duct and close to alveolar air, since the right duct
carries lymph from non-gas exchanging areas as well
as from alveoli. Lung lymph could not be collected
in the remaining 241 dogs because of technical difficulties and communication between the right and
thoracic ducts (in 16% of the animals). The possibility of diffusion of oxygen through the walls of the
right duct and smaller lymphatics made interpretation
of the P02 values for lymph of the right duct difficult.
A counter-current diffusion exchange mechanism of
oxygen between pulmonary arterial blood and pulmonary lymphatic vessels appeared possible. The right
duct lymph PC02 was similar to arterial PCO,. The
right duct lymph pH was higher than the pH of either
the thoracic duct lymph or the arterial blood.
Pulmonary lymph flow was estimated to constitute
about 40 % of lymph flow from the right duct. Simultaneous measurements in 28 dogs showed mean values
of 4.5 and 24.6 ml/ hr, respectively, for control lymph
flow from the right and thoracic ducts. The flow
from the right duct was related to tidal volume but
not to the body weight of the animal. It was found
that left atrial pressures below those generally believed
to cause pulmonary edema, e.g., 10 or 15 mm Hg,
increased flow from the right duct.. This finding could
only be explained by the presence of interstitial tissue
pressure around the pulmonary capillaries. Hypoxia
induced by low 0 2 breathing and i.v. administration of
dinitrophenol increased the pulmonary lymph flow,
probably because of increased capillary permeability.
Alloxan increased lung lymph flow markedly. Hyperoxia ( 100% 0 2 breathing) did not change the rate
of pulmonary lymph flow.
MCV QUARTERLY 4(1): 41 -44, 1968

The order of seven mutant genes, one dominant
and six recessive, in the X-chromosome of Drosophila
tropicalis has been determined and a linkage map
constructed. The recombination frequencies for some
of the seven genes varied in different crosses, which
may have been a result of variability associated with
the different strains used in this study.
When compared to the X-chromosome linkage map
of some other species that also possess a metacentric
X-chromosome, the region of 36 units mapped in D .
tropicalis appears much shorter and thus probably represents only a segment of the whole X-chromosome.
This is almost certainly true because of the small
number of sex-linked mutants known in this species.
As more sex-linked mutants are found, the map
distance will likely increase because of the probability
of finding genes near both ends of the chromosome.
Comparison of the X-chromosomes of D. tropicalis
and D. willistoni was made, using the presumed
homologous mutants. Three schemes have been presented to illustrate inversion sequences that may have
taken place between these two species. Both overlapping and included inversions would result in a similar
gene order.

A Study of Some Factors Affecting Starch
Swelling and their Relationships to Tablet
Disintegration
JAMES THOMAS INGRAM, M.S.
Department of Pharmacy

The project was planned to study some factors
influencing starch swelling at 37° C. and their relationships to tablet disintegration. The swelling capability of starch was determined by microscopic examination. One hundred or 200-grain diameters were
measured for each environmental condition. The
mean grain diameters were compared in various full
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factorial experimental designs to determine whether
changes in environmental conditions produced significant changes in grain diameters. This statistical significance was determined by calculation of analyses of
variance and application of F-ratio tests.
To determine the relationships between starch swelling and tablet disintegration, tablets of various materials
were prepared with cornstarch as the disintegrant.
These tablets were studied for the correlations between
compressional force, disintegration time, starch grain
damage, void space and elastic recovery.
Cornstarch and amioca starch, when submersed
5 to 30 minutes in simulated gastric fluid USP (SGF),
had greater increases in grain sizes than when submersed in distilled water.
The effects of the individual components of SGF
were examined. Changes in pH had little effect on
swelling. Salts affected swelling, with polyvalent cationic salts (MgCl, and AlCls) producing greater
diameter increases than monovalent cationic salts
(NaCl and Na.,SO,). Ionic concentration did not produce an effect on swelling. There was no statistically
significant swelling demonstrated by pepsin or surfactants in the submersion medium.
No significant difference in swelling was demonstrated between the various time intervals. However,
when unsubmersed starches were included in the
analyses, significant differences were shown between
the unsubmersed starches and the starches slurried
for five minutes and longer.
The swelling of starch grains was in the order of
5% to 10% increase in mean grain diameter. This
was calculated to represent a volume increase of about
1.1 % to 5.5 % in a tablet containing 10% cornstarch.
Since most tablets contain more than 5.5% void
space, this did not seem to be a large enough change
to cause the tablet to rupture.
The literature review indicated that damaged starch
grains will swell in cold water. This was demonstrated
by experiments with cornstarch damaged by ball milling. Submersion of the starch samples that had been
ball milled from 10 to 48 hours produced increases
in grain diameters of 40% to 80%.
Since damaged starch grains were shown to have
an increased swelling capability in SGF at 37° C., the
effect of the tableting procedure on starch grain
damage was investigated. Damage to the grains, resulting from compression of pure cornstarch, was
shown to be insignificant.
The effect of compressional force and hardness of
the tablet ingredients was examined. In each formulation the starch grain damage increased as the compressional force was increased. The ingredient apparently had no effect on the direct proportionality of
this relationship but did have an effect on the degree to
which it occurred. There was no correlation between
degree of starch grain damage and hardness of the
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ingredient. The crystalline form of the ingredient may
exert a greater influence on starch damage than hardness. There was no correlation between starch damage
and stress produced by elastic recovery of the tablet
after removal of pressure. Contrary to what might be
expected, there was an inverse relation between the
amount of stress and the degree of starch grain
damage for all of the formulations except aspirin.
There was no evident relationship demonstrated
between disintegration time and starch grain damage.
Other than compressional force, the inherent effect
of the tablet ingredient was the only factor that appeared to affect disintegration.
The long accepted swelling mechanism of starch as
a tablet disintegrant was not demonstrated in this
study. The results of the investigation revealed no
measureable correlations between starch grain damage
and disintegration or between starch swelling and
disintegration.

Circulatory Effect of Hypercapnia and its
Role in the Production of the Vasodilator
Response to lschemia
HERMES A . KONTOS, Ph.D.

Department of Physiology

Despite extensive studies, the magnitude of the
vasodilator effect of CO, on blood vessels in skin and
muscle and its role in the local regulation of blood
flow are still controversial.
In the present work the vasodilator effect of CO,
in the human forearm was evaluated quantitatively,
its mechanism of action was investigated, and its role
in the production of the vasodilator response to
ischemia was determined.
One hundred and twenty-seven experiments were
carried out in 66 normal human volunteers. Forearm
blood flow was measured by venous occlusion plythesmography. The vasoconstrictor effect of increased
activity of sympathetic nerves and of circulating catecholamines was inhibited by the induction of alphaadrenergic blockade through intra-arterial administration of phenoxybenzamine. In most experiments the
dilator effect of circulating catecholamines was also
eliminated by producing -beta-adrenergic blockade
through intra-arterial administration of propanalol or
pronethalol.
Hypercapnia, produced by breathing 2.8% to 9 %
C02 in air, caused increase in forearm blood flow
and decrease in forearm vascular resistance. In the
steady state the decrease in vascular resistance during
hypercapnia was related to the change in venous blood
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PC02 or pH by a semilogarithmic relationship. In
several experiments the decrease in vascular resistance
during CO. breathing was produced by a short-lasting,
small increase in vascular resistance.
In another series of experiments, the vasodilator
effect of local hypercapnia was evaluated in the intact
forearm in the following manner: isotonic saline equilibrated with 100% co. was infused intra-arterially
and its effect on forearm blood flow determined. During the infusion of saline with high C02 tension, forearm blood flow displayed a biphasic response consisting of a small initial decrease in flow followed by a
more pronounced increase in blood flow. These experiments indicated that C02 has a local vasodilator effect
on vessels of the human forearm.
Another series of experiments was undertaken to
determine whether the stimulus for the CO.-produced
vasodilatation was increased PCO. or decreased pH.
For this purpose, subjects breathed 7 % C02 for two 10
minute periods. During one of these periods, decrease
in pH in response to CO. breathing was abolished by
the intravenous administration of sodium bicarbonate.
The changes in forearm blood flow in forearm vascular
resistance during the two periods were not significantly different, indicating that the stimulus for the
C02 -produced vasodilatation is increased PCO. rather
than decreased pH.
The roles of local hypercapnia and local hypoxia in
the production of the vasodilator response to ischemia
were evaluated in the human forearm in the following
manner : ischemia was produced by digital compression of the brachia! artery, and the collateral flow was
allowed to perfuse the forearm, while venous blood
was withdrawn during the period of ischemia to determine the magnitude of the increase in PCO. and decrease in P02 • The vasodilator response to ischemia
was then compared to that produced by: a) increase
in venous blood PC02 produced by CO. breathing,
when the circulation was free; or b) decrease in venous
blood P02 , similar to that produced by ischemia, induced by breathing gas mixtures containing low concentration of oxygen, when the circulation was free ;
or c) increase in venous blood PCO. and decrease in
venous blood P02 , comparable to those changes produced by ischemia, induced by breathing gas mixtures
having high concentration of CO. and low concentration of oxygen when the circulation was free. It was
found that local hypercapnia accounted for about
50 % to 60% of the vasodilator response to ischemia,
while the contribution of local hypoxia was much less
important, amounting to about 20 % of the response
to ischemia. It was found, furthermore, that the response to ischemia was not changed during 100 %
oxygen breathing, in spite of the fact that a substantial
increase in venous blood PO. occurred, confirming the
view that the contribution of local hypoxia to the
response to ischemia is not pronounced.

The Initial Destruction of Intracellular

Salmonella typhimurium
ANNA SYBIL RADCLIFFE, M.S.

Department of Microbiology

An experimental procedure was designed for the
in vitro cultivation of macrophages infected with
Salmonella typhimurium. Peritoneal macrophages from
guinea pigs were permitted to phagocytize S. typhimurium and were cultured in suspension. At intervals, samples were taken for determination of total cell
population and for quantitative recovery of cell-associated bacteria. The ratio of bacteria to cells was thus
computed at each interval, and a curve was constructed representing the fate of intracellular parasites
over a period of time after phagocytosis.
Two strains of S. typhimurium with different degrees of virulence against mice were compared by the
above procedure. Data show that there is an initial destruction of intracellular bacteria of both strains. However, there is a difference in the extent of this intracellular destruction. With the avirulent strain there is a
two-log decrease in the intracellular population, the
minimum being reached in four hours after phagocytosis; whereas with the virulent strain there is only a
1.2 log decline in the intracellular population, its
minimum being reached in three hours. After this
period of decline, the surviving organisms in both
strains begin to multiply.

Cell Culture of Oral Mucous
Membrane Lesions
RAYMOND PETRIE WHITE, JR., Ph.D.

Department of Anatomy

The difficulty in recognizing the malignant potential of oral lesions is well appreciated by the clinician
who faces this problem routinely. In an effort to provide information which may aid in determining the
potential of these lesions, a tissue culture project was
undertaken.
The specific aims of this project were : a) the development of a reliable in vitro system for the growth
of normal cheek-pouch mucosa of the hamster, and
b) the comparison of the growth of this normal mucosa with the growth of 9, 10-dimethyl-1, 2-benzanthracene (DMBA)-induced lesions of the hamster
pouch.
The hamster mucosa! lesions were produced by repeatedly painting the animal's cheek pouch with 0.5 %
DMBA, the opposite pouch in the same animal being
used as a control. Biopsies of these areas were taken
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from the time the painting with the carcinogen began
until obvious tumors appeared. A part of this tissue
was preserved for histologic sectioning. The remaining
tissue was explanted into Sykes-Moore chambers.
These chambers were then incubated at 36±0.5° C.
in a standard water jacket incubator. Eagle's Minimum
Essential Medium with 10% Fetal Bovine Serum was
used as a growth medium. Developing cell sheets in the
Sykes-Moore chambers were observed with phase
microscopy up to a 30-day maximum.
The tissue preserved for histologic sectioning was
fixed in formalin, and routine H & E sections were
prepared. Based on these sections, the tissue from the
painted cheek pouches was divided into three categories: hyperplastic, early carcinomic, and late carcinomic. On this basis the tissues in culture could be
compared.
Results of the pilot study indicated that primary cell
cultures of hamster cheek-pouch epithelial cells could
be repeatedly grown using a plasma clot explant culture technique. Twenty-four of 25 control cultures produced epithelial cell sheets in the first three postexplant days. Fibroblasts appeared later in these cultures, normally about the fifth post-explant day. These
cells did not compromise the growth of the epithelial
cells.
Cell size in this pilot study seemed to be a good indicator of growth activity. As long as small or
medium cells could be found in the cell sheet, growth
activity would continue until the next observation of
that culture.
Epithelial cell sheets developed from the control tissue in a typical pattern. This process was followed
from the initial appearance of cells around the explant
until the continuity of the c:ell sheets was broken and
the cells themselves had degenerated.
Three other experiments were carried out to confirm the results of the pilot study and to better compare the cultures of pathologic tissue with the cultures
of normal tissue. Two of these experiments used a
blind experimental design, so that the cultures from
pathologic tissue were not identified until culture
growth had terminated. The results of all three experiments were similar.
The cultures of normal tissue behaved much like
cultures of normal tissue in the pilot study. Early
epithelial cell sheets developed with a similar pattern
whether they were from normal or pathologic mucosa.
Cell size continued to be a good indicator of growth
activity. The control cultures uniformly exhibited epithelial cell sheets in the first three post-explant days.
However, none of the normal tissue samples produced cultures whose cell sheets persisted through the
30-day observation period.
In contrast many cultures of pathologic tissue
showed poor growth or no growth at all. A large
amount of granular debris was often seen accumu44

lated around the explant, particularly in cultures from
the later stages of carcinoma development. However,
in each experiment cultures of pathologic tissue exhibited intense growth activity that persisted for the
maximum observation period. These cell sheets were
filled with small pleomorphic cells which were often
piled one cell on another. Often the nucleus filled the
cell. This type of cellular growth was seen in cultures
from all three classes of pathologic tissue. No real
comparison could be made among the classes of pathologic tissue since the number of early carcinoma and
late carcinoma biopsy samples was small.
In contrast to previous reports in the literature,
several types of lesions were produced with DMBA
painting. The classic lesion described is an exophytic
lesion that progresses to a well-differentiated carcinoma. Both endophytic and exophytic lesions were
seen in this project. Some of these were highly cellular;
others appeared invasive, with a minimum total number of involved cells.
In summary, the growth of pathologic mucosa in
culture differed from normal mucosa. The clinical
significance of these findin gs remains to be determined.
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Book Review
Vaginal Cytology. Grimaldo Carvalho, (ed.). New York, New York:
Vantage Press, 1968. 163 p. $5.95.

Dr. Carvalho's book, VAGINAL
CYTOLOGY, offers an inexpensive, brief, and clear survey of
the various uses to which vaginal
cytology is now applied. The book
presents an orderly approach to the
diagnostic uses to which cytology
may be put in clinical endocrinology, complications of pregnancy,
diagnosis of malignancy, and prediction of radiation sensitivity. The
author's long experience, not only
with cytology but also with clinical gynecology, is apparent from
the clinical references sprinkled
throughout the text and the clear
descriptive terms pertaining to the
smears themselves.
The text is easy to read, the descriptions are clearly stated, and
the pathologist's usual addiction to
descriptive terms such as "beer
bottle caps" and " tennis rackets"
is used to good advantage to describe some of the unusual cellular
morphology. The illustrative material is obviously derived from a
large collection which makes available both common findings and
the rare and unexpected. Although
the illustrations are well selected
and abundant, the lack of color
is a disadvantage, and they are
somewhat disappointing in that
they are poorly reproduced in
many of the plates. The illustrations are so plentiful that one feels
that perhaps the text could have
been placed in juxtaposition with
the illustrations, thereby proving of
greater advantage to the reader.
All controversy regarding the
uses of cytology other than for the
diagnosis of malignancy is omitted.
The skeptical physician who does
not readily accept the cytologist's
ability to diagnose such entities as
ectopic pregnancy, impending labor, impending abortion, and ra-

diation sensitivity will find little to
convince him of the cytologist's
claims. The material relating to
these disorders is largely descriptive, and documentation of accuracy is not attempted. If not convincing, Dr. Carvalho's claims for
the use of cytology in these entities is at least provocative.
The author and his associates
are to be congratulated on producing a readable, convenient text
that should find ready acceptance
as a brief and clear review of the
uses of cytology for those who are
not actively engaged in this type
of work. For the experienced cytologist and pathologist, Dr. Carvalho's observations regarding diagnosis of ectopic pregnancy, diabetes,
and "phagocytic response" in patients undergoing radiation therapy should be a stimulus for further investigation.
Leo J . Dunn, M.D.
Professor and Chairman
Department of Obstetrics
and Gynecology
Medical College of Virginia
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Elected to Associate Membership
Archie Jay Beebe
Dr. Jennifer Anne Castleden
William Guy Crouthamel
Michael Lewis Edwards
Promoted to Full Membership
Dr.
Dr.
Dr.
Dr.
Dr.

Judith Carol Bond
Patricia Montague Hudgins
Joseph Pollara Liberti
John Adam Rosecrans
Muhammad S. Sahli

Elected to Full Membership
Richard Charles Allen
Dr. Marvin Jerome Allison
Dr. William Desmond DeHart
Dr. Lyman McArthur Fisher
Dr. Peter Franklin Jezyk
George Henry Miller
Dr. Raphael Martin Ottenbrite
Dr. Federico Peradejordi
Dr. Novera Herbert Spector

Charles M. Caravati (Cirrhosis: What ls It?), assistant dean in charge of continuing education at the Medical College
of Virginia, received his undergraduate education at the University of Richmond and his M.D. from MCV. After two
years of internship and assistant residency at Providence Hospital in' Washington, he returned to Richmond for private
practice in internal medicine and gastroenterology and joined the faculty of MCV. Dr. Caravati has also served as chairman
of the division of gastroenterology at MCV.
Robert M. Donaldson, Jr. (The Relation of Intestinal Cell Surface to Vitamin Bu Absorption) is director of the gastrointestinal division at University Hospital in Boston. He received his B.S. from Yale University and his M.D. from the Boston
University School of Medicine. Following his internship at Montreal General Hospital, he was assigned to general medical
duty in the U.S. Naval Reserve. He returned to civilian life as resident at the Boston Veteran's Administration Hospital
and was subsequently a U.S.P.H.S. fellow at Peter Bent Brigham Hospital. Before assuming his present position, Dr.
Donaldson was director of the patient study unit at University Hospitals in Madison, Wisconsin.

Bertram Fleshier (Amino-Acid Absorption), associate professor of medicine at Case Western Reserve University, received his A.B. degree from the University of Wisconsin and his M.D. from Boston University School of Medicine. After
completing his internship at Massachusetts Memorial Hospital and assistant residency at Georgetown University Hospital,
Dr. Fleshier served as a Captain in the United States Air Force Medical Corps. Before coming to Case-Western Reserve,
he was a U.S.P.H.S. postdoctoral fellow at Massachusetts Memorial Hospital. Dr. Fleshier is also director of the division
of gastroenterology at the Cleveland Metropolitan General Hospital.
Franz J. lngelfinger (Clinical Manifestations of Pancreatic Disease), editor of THE NEW ENGLAND JOURNAL OF
MEDICINE and former president of the American Gastroenterological Association, received his A.B. degree from Yale
University and his M.D. from Harvard Medical School. Following house-staff training at Boston City Hospital, he spent
a year at the University of Pennsylvania collaborating in the early studies of human small intestinal physiology. From
1940 to 1961 he was director of the division of gastroenterology at the Evans Memorial and Boston University School of
Medicine. Before accepting his current position, Dr. lngelfinger was director of the Boston University Medical Services
at Boston City Hospital.
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Lester W. Martin (The Surgical Management of Hirschsprung's Disease) is associate professor of surgery at the University of Cincinnati and director of pediatric surgery at the Cincinnati Children's Hospital. Hereceivedhis undergraduate
education at the University of Missouri, his M.D. at Harvard University, and his hospital training at The New York
Hospital. Dr. Martin has held a variety of teaching positions at Cornell and Harvard Medical Schools, Brooke Army
Medical Center, and Simmons College. At the present time he is also attending surgeon at the Cincinnati General Hospital.
Z. Reno Vlahcevic (Pathogenesis and Treatment of Hepatic Coma) is assistant professor of medicine at the Medical
College of Virginia and staff physician at the Veteran's Administration Hospital, Richmond. Born in Zagreb, Yugoslavia,
he received his M.D. degrees from the Medical School of the University Zagreb. After coming to the United States, he
completed internship at the Salem Hospital in Salem, Massachusetts. Following that, Dr. Vlahcevic served on the faculties
of Tufts and Western Reserve Medical Schools.
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the "spasm reactor" in your practice

The Machine Age man still possesses a Stone Age stomach; sometimes the job of merely coping with today's
environmental stress may prove too much. For some
(the "spasm reactors" in your practice), tension, anxiety and worry may find expression through the voice of
gastrointestinal or other smooth muscle spasm. To treat
these patients with antispasmodics alone is often to
miss the point of origin .of their disturbance; to rely
solely on tranquilizers often proves discouragingly slow
or ineffective in relieving spasm and pain.

To quiet and quell

Donnatal can promptly and effectively quell the spasm and quiet the tensions that trigger
it. Prescribed by more physicians than any other antispasmodic-sedative, Donnatal continues to provide the
classic answer.

The "Donnatal Effect" The characteristic, over-all
effect of Donnatal has been observed in many thousands
of children and adults, clearly establishing its value as
a versatile sedative-antispasmodic. Outstanding in effectiveness, safety, economy, uniformity of composition
and dosage convenience, Donnatal continues to be desired and prescribed by a majority of physicians.

when the
'~ut issues"
get to him
he deserves

In a multiplicity of indications Particularly useful
when anxiety and tension accompany, aggravate or account for smooth muscle spasm, Donnatal is indicated
for the symptomatic relief of recurring, persistent or
chronic visceral spasm.
Brief summary Blurring of vision, dry mouth, difficult urination, and flushing or dryness of the skin may
occur on higher dosage levels, rarely on usual dosage.
Administer with caution to patients with incipient glaucoma or urinary bladder neck obstruction. Contraindicated in acute glaucoma, advanced renal or hepatic
disease or a hypersensitivity to any of the ingredients.
each tablet, capsule or
each
5cc. of elixir (23% alcohol)
Extentab®
hyoscyamine sulfate ................ 0.1037 mg.
0.3111 mg.
atropine sulfate ........................ 0.0194 mg.
0.0582 mg.
hyoscine hydrobromide ............ 0.0065 mg.
0.0195 mg.
phenobarbital .................... ( 1.4 gr.) 16.2 mg.
( % gr.) 48.6 mg.
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QUIETS THE STRESS I QUELLS THE SPASM

.. H, ROS I NS COMPANY, RI CHMOND, VI RGINIA

A·H·ROBINS

Whenever anxiety induces or intensifies clinical symptoms

______i

•

rtum®

(chlordiazepoxide HCl)
Quickly relieves anxiety-Helps improve response in
psychophysiologic disorders-Seldom impairs
mental acuity or physical coordination, on proper dosageHas wide margin ofsafety

Before prescribing, please consult complete
product information, a summary of which
follows:
Indications: Indicated when anxiety, tension
and apprehension are significant components
of the clinical profile.
Contraindications: Patients with known
hypersensitivity to the drug.
Warnings: Caution patients about possible
combined effects with alcohol and other CNS
depressants. As with all CNS-acting drugs,
caution patients against hazardous occupations
requiring complete mental alertness (e.g.,
operating machinery, driving) .Though physical and psychological dependence have rarely
been reported on recommended doses, use caution in administering to addiction-prone individuals or those who might increase dosage;
withdrawal symptoms (including convulsions),
following discontinuation of the drug and
similar to those seen with barbiturates, have
been reported. Use of any drug in pregnancy,
lactation, or in women of childbearing age
requires that its potential benefits be weighed
against its possible hazards.
Precautions: In the elderly and debilitated,
and in children over six, limit to smallest effective dosage (initially 10 mg or less per day) to
preclude ataxia or overseda'cion, increasing

gradually as needed and tolerated. Not recommended in children under six. Though generally not recommended, if combination therapy
with other psychotropics seems indicated,
carefully consider individual pharmacologic
effects, particularly in use of potentiating
drugs such as MAO inhibitors and phenothiazines. Observe usual precautions in presence of
impaired renal or hepatic function. Paradoxical reactions (e.g., excitement, stimulation and
acute rage) have been reported in psychiatric
patients and hyperactive aggressive children.
Employ usual precautions in treatment of anxiety states with evidence of impending depression; suicidal tendencies may be present and
protective measures necessary. Variable effects
on blood coagulation have been reported very
rarely in patients receiving the drug and oral
anticoagulants; causal relationship has not
been established clinically.
Adverse Reactions: Drowsiness, ataxia and
confusion may occur, especially in the elderly
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Division of Hoffmann - La Roche Inc.
Nutley, New Jersey 07110

and debilitated. These are reversible in most
instances by proper dosage adjustment, but are
also occasionally observed at the lower dosage
ranges. In a few instances syncope has been
reported. Also encountered are isolated instances of skin eruptions, edema, minor menstrual irregularities, nausea and constipation,
extrapyramidal symptoms, increased and decreased libido-all infrequent and generally
controlled with dosage reduction; changes in
EEG patterns (low-voltage fast activity) may
appear during and after treatment; blood dyscrasias (including agranulocycosis), jaundice
and hepatic dysfunction have been reported
occasionally, making periodic blood counts
and liver function tests advisable during protracted therapy.
Usual Daily Dosage: Individualize for maxi·
mum beneficial effects. Oral-Adults: Mild
and moderate anxiety and tension, 5 or 10 mg
t.i.d. or q.i.d.; severe states, 20 or 25 mg t.i.d.
or q.i.d. Geriatric patients: 5 mg b.i.d. to
q.i.d. (See Precautions.)
Supplied: Librium® (chlordiazepoxide HCI)
Capsules, 5 mg, 10 mg and 2 5 mg-bottles of
50. LibritabsT.M. (chlordiazepoxide) Tablets,
5 mg, 10 mg and 25 mg-bottles of 100. With
respect to clinical activity, capsules and tablets
are indistinguishable.

Also available.· LibritabsM(chlordiazepoxide) 5-mg, 10-mg, 25-mg tablets

